{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:07:44Z","timestamp":1791925664827,"version":"4.3.4"},"reference-count":352,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T00:00:00Z","timestamp":1534464000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Drug Discov"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1038\/nrd.2018.109","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T01:06:11Z","timestamp":1534467971000},"page":"660-688","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":529,"title":["Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing"],"prefix":"10.1038","volume":"17","author":[{"given":"Barry","family":"Boland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Haung","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Mollereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"Bezard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg M.","family":"Pastores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Rubinsztein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph A.","family":"Nixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Duchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna R.","family":"Mallucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Kroemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eeva-Liisa","family":"Eskelinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Mochel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Spedding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier R.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Millan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,17]]},"reference":[{"key":"BFnrd2018109_CR1","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.neuron.2017.01.022","volume":"93","author":"FM Menzies","year":"2017","unstructured":"Menzies, F. M. et al. Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities. Neuron 93, 1015\u20131034 (2017).","journal-title":"Neuron"},{"key":"BFnrd2018109_CR2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fnins.2017.00185","volume":"11","author":"A Ciechanover","year":"2017","unstructured":"Ciechanover, A. & Kwon, Y. T. Protein quality control by molecular chaperones in neurodegeneration. Front. Neurosci. 11, 185 (2017).","journal-title":"Front. Neurosci."},{"key":"BFnrd2018109_CR3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev-biochem-061516-044908","volume":"86","author":"I Dikic","year":"2017","unstructured":"Dikic, I. Proteasomal and autophagic degradation systems. Annu. Rev. Biochem. 86, 193\u2013224 (2017).","journal-title":"Annu. Rev. Biochem."},{"key":"BFnrd2018109_CR4","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.15252\/embj.201796697","volume":"36","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi, L. et al. Molecular definitions of autophagy and related processes. EMBO J. 36, 1811\u20131836 (2017).","journal-title":"EMBO J."},{"key":"BFnrd2018109_CR5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrd.2017.22","volume":"16","author":"L Galluzzi","year":"2017","unstructured":"Galluzzi, L., Bravo- San Pedro, J. M., Levine, B., Green, D. R. & Kroemer, G. Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nat. Rev. Drug Discov. 16, 487\u2013511 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnrd2018109_CR6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/bpa.12538","volume":"27","author":"I Ferrer","year":"2017","unstructured":"Ferrer, I. Diversity of astroglial responses across human neurodegenerative disorders and brain aging. Brain Pathol. 27, 645\u2013674 (2017).","journal-title":"Brain Pathol."},{"key":"BFnrd2018109_CR7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.molmed.2017.03.008","volume":"23","author":"FL Yeh","year":"2017","unstructured":"Yeh, F. L., Hansen, D. V. & Sheng, M. TREM2, microglia, and neurodegenerative diseases. Trends Mol. Med. 23, 512\u2013533 (2017).","journal-title":"Trends Mol. Med."},{"key":"BFnrd2018109_CR8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fnmol.2014.00073","volume":"7","author":"AH Jansen","year":"2014","unstructured":"Jansen, A. H., Reits, E. A. & Hol, E. M. The ubiquitin proteasome system in glia and its role in neurodegenerative diseases. Front. Mol. Neurosci. 7, 73 (2014).","journal-title":"Front. Mol. Neurosci."},{"key":"BFnrd2018109_CR9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tins.2017.01.002","volume":"40","author":"JS Kerr","year":"2017","unstructured":"Kerr, J. S. et al. Mitophagy and Alzheimer's disease: cellular and molecular mechanisms. Trends Neurosci. 40, 151\u2013166 (2017).","journal-title":"Trends Neurosci."},{"key":"BFnrd2018109_CR10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jmb.2016.12.013","volume":"429","author":"D Molino","year":"2017","unstructured":"Molino, D., Zemirli, N., Codogno, P. & Morel, E. The journey of the autophagosome through mammalian cell organelles and membranes. J. Mol. Biol. 429, 497\u2013514 (2017).","journal-title":"J. Mol. Biol."},{"key":"BFnrd2018109_CR11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cell.2016.11.042","volume":"168","author":"Y Wei","year":"2017","unstructured":"Wei, Y. et al. Prohibitin 2 is an inner mitochondrial membrane mitophagy receptor. Cell 168, 224\u2013238.e10 (2017).","journal-title":"Cell"},{"key":"BFnrd2018109_CR12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.tcb.2015.08.010","volume":"26","author":"A Khaminets","year":"2016","unstructured":"Khaminets, A., Behl, C. & Dikic, I. Ubiquitin-dependent and independent signals in selective autophagy. Trends Cell Biol. 26, 6\u201316 (2016).","journal-title":"Trends Cell Biol."},{"key":"BFnrd2018109_CR13","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1007\/s11064-015-1631-0","volume":"40","author":"K Banerjee","year":"2015","unstructured":"Banerjee, K., Munshi, S., Frank, D. E. & Gibson, G. E. Abnormal glucose metabolism in alzheimer's disease: relation to autophagy\/mitophagy and therapeutic approaches. Neurochem. Res. 40, 2557\u20132569 (2015).","journal-title":"Neurochem. Res."},{"key":"BFnrd2018109_CR14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1083\/jcb.200412022","volume":"169","author":"M Komatsu","year":"2005","unstructured":"Komatsu, M. et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J. Cell Biol. 169, 425\u2013434 (2005).","journal-title":"J. Cell Biol."},{"key":"BFnrd2018109_CR15","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1007\/s12035-015-9453-2","volume":"53","author":"J Fekadu","year":"2016","unstructured":"Fekadu, J. & Rami, A. Beclin-1 deficiency alters autophagosome formation, lysosome biogenesis and enhances neuronal vulnerability of HT22 hippocampal cells. Mol. Neurobiol. 53, 5500\u20135509 (2016).","journal-title":"Mol. Neurobiol."},{"key":"BFnrd2018109_CR16","doi-asserted-by":"crossref","first-page":"7817","DOI":"10.1523\/JNEUROSCI.6412-10.2011","volume":"31","author":"S Lee","year":"2011","unstructured":"Lee, S., Sato, Y. & Nixon, R. A. Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer's-like axonal dystrophy. J. Neurosci. 31, 7817\u20137830 (2011).","journal-title":"J. Neurosci."},{"key":"BFnrd2018109_CR17","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1523\/JNEUROSCI.0800-08.2008","volume":"28","author":"B Boland","year":"2008","unstructured":"Boland, B. et al. Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J. Neurosci. 28, 6926\u20136937 (2008).","journal-title":"J. Neurosci."},{"key":"BFnrd2018109_CR18","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.3232","volume":"19","author":"RA Nixon","year":"2013","unstructured":"Nixon, R. A. The role of autophagy in neurodegenerative disease. Nat. Med. 19, 983\u2013997 (2013).","journal-title":"Nat. Med."},{"key":"BFnrd2018109_CR19","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrd3802","volume":"11","author":"DC Rubinsztein","year":"2012","unstructured":"Rubinsztein, D. C., Codogno, P. & Levine, B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat. Rev. Drug Discov. 11, 709\u2013730 (2012).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnrd2018109_CR20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrm3716","volume":"15","author":"J Fullgrabe","year":"2014","unstructured":"Fullgrabe, J., Klionsky, D. J. & Joseph, B. The return of the nucleus: transcriptional and epigenetic control of autophagy. Nat. Rev. Mol. Cell Biol. 15, 65\u201374 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnrd2018109_CR21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2017","unstructured":"Herzig, S. & Shaw, R. J. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat. Rev. Mol. Cell Biol. 19, 121\u2013135 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnrd2018109_CR22","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1242\/jcs.188920","volume":"129","author":"J Fullgrabe","year":"2016","unstructured":"Fullgrabe, J., Ghislat, G., Cho, D. H. & Rubinsztein, D. C. Transcriptional regulation of mammalian autophagy at a glance. J. Cell Sci. 129, 3059\u20133066 (2016).","journal-title":"J. Cell Sci."},{"key":"BFnrd2018109_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","volume":"12","author":"DJ Klionsky","year":"2016","unstructured":"Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12, 1\u2013222 (2016).","journal-title":"Autophagy"},{"key":"BFnrd2018109_CR24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tips.2013.12.004","volume":"35","author":"BP Hubbard","year":"2014","unstructured":"Hubbard, B. P. & Sinclair, D. A. Small molecule SIRT1 activators for the treatment of aging and age-related diseases. Trends Pharmacol. Sci. 35, 146\u2013154 (2014).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnrd2018109_CR25","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.15252\/embj.201695810","volume":"36","author":"S Camandola","year":"2017","unstructured":"Camandola, S. & Mattson, M. P. Brain metabolism in health, aging, and neurodegeneration. EMBO J. 36, 1474\u20131492 (2017).","journal-title":"EMBO J."},{"key":"BFnrd2018109_CR26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1042\/EBC20170091","volume":"61","author":"J Fraser","year":"2017","unstructured":"Fraser, J., Cabodevilla, A. G., Simpson, J. & Gammoh, N. Interplay of autophagy, receptor tyrosine kinase signalling and endocytic trafficking. Essays Biochem. 61, 597\u2013607 (2017).","journal-title":"Essays Biochem."},{"key":"BFnrd2018109_CR27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.tem.2014.03.006","volume":"25","author":"EM Wauson","year":"2014","unstructured":"Wauson, E. M., Dbouk, H. A., Ghosh, A. B. & Cobb, M. H. G protein-coupled receptors and the regulation of autophagy. Trends Endocrinol. Metab. 25, 274\u2013282 (2014).","journal-title":"Trends Endocrinol. Metab."},{"key":"BFnrd2018109_CR28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/15548627.2017.1384887","volume":"14","author":"A Kondratskyi","year":"2017","unstructured":"Kondratskyi, A., Kondratska, K., Skryma, R., Klionsky, D. J. & Prevarskaya, N. Ion channels in the regulation of autophagy. Autophagy 14, 3\u201321 (2017).","journal-title":"Autophagy"},{"key":"BFnrd2018109_CR29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.coph.2017.02.001","volume":"32","author":"Y Huang","year":"2017","unstructured":"Huang, Y., Todd, N. & Thathiah, A. The role of GPCRs in neurodegenerative diseases: avenues for therapeutic intervention. Curr. Opin. Pharmacol. 32, 96\u2013110 (2017).","journal-title":"Curr. Opin. Pharmacol."},{"key":"BFnrd2018109_CR30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev-genet-102808-114910","volume":"43","author":"C He","year":"2009","unstructured":"He, C. & Klionsky, D. J. Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 43, 67\u201393 (2009).","journal-title":"Annu. Rev. Genet."},{"key":"BFnrd2018109_CR31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim, J., Kundu, M., Viollet, B. & Guan, K. L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13, 132\u2013141 (2011).","journal-title":"Nat. Cell Biol."},{"key":"BFnrd2018109_CR32","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1080\/15548627.2017.1320635","volume":"13","author":"H Pan","year":"2017","unstructured":"Pan, H., Yan, Y., Liu, C. & Finkel, T. The role of ZKSCAN3 in the transcriptional regulation of autophagy. Autophagy 13, 1235\u20131238 (2017).","journal-title":"Autophagy"},{"key":"BFnrd2018109_CR33","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1126\/science.aaf6136","volume":"354","author":"K Tsuboyama","year":"2016","unstructured":"Tsuboyama, K. et al. The ATG conjugation systems are important for degradation of the inner autophagosomal membrane. Science 354, 1036\u20131041 (2016).","journal-title":"Science"},{"key":"BFnrd2018109_CR34","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1083\/jcb.201612148","volume":"216","author":"S Gowrishankar","year":"2017","unstructured":"Gowrishankar, S., Wu, Y. & Ferguson, S. M. Impaired JIP3-dependent axonal lysosome transport promotes amyloid plaque pathology. J. Cell Biol. 216, 3291\u20133305 (2017).","journal-title":"J. Cell Biol."},{"key":"BFnrd2018109_CR35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.brainres.2016.03.047","volume":"1649","author":"S Maday","year":"2016","unstructured":"Maday, S. Mechanisms of neuronal homeostasis: autophagy in the axon. Brain Res. 1649, 143\u2013150 (2016).","journal-title":"Brain Res."},{"key":"BFnrd2018109_CR36","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1093\/hmg\/ddx321","volume":"26","author":"P Tammineni","year":"2017","unstructured":"Tammineni, P., Jeong, Y. Y., Feng, T., Aikal, D. & Cai, Q. Impaired axonal retrograde trafficking of the retromer complex augments lysosomal deficits in Alzheimer's disease neurons. Hum. Mol. Genet. 26, 4352\u20134366 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrd2018109_CR37","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s13311-014-0321-y","volume":"12","author":"DE Berman","year":"2015","unstructured":"Berman, D. E., Ringe, D., Petsko, G. A. & Small, S. A. The use of pharmacological retromer chaperones in Alzheimer's disease and other endosomal-related disorders. Neurotherapeutics 12, 12\u201318 (2015).","journal-title":"Neurotherapeutics"},{"key":"BFnrd2018109_CR38","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1016\/j.jmb.2016.10.029","volume":"428","author":"S Martens","year":"2016","unstructured":"Martens, S., Nakamura, S. & Yoshimori, T. Phospholipids in autophagosome formation and fusion. J. Mol. Biol. 428, 4819\u20134827 (2016).","journal-title":"J. Mol. Biol."},{"key":"BFnrd2018109_CR39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbapap.2011.05.013","volume":"1824","author":"V Kaminskyy","year":"2012","unstructured":"Kaminskyy, V. & Zhivotovsky, B. Proteases in autophagy. Biochim. Biophys. Acta 1824, 44\u201350 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrd2018109_CR40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.arr.2016.05.004","volume":"32","author":"DJ Colacurcio","year":"2016","unstructured":"Colacurcio, D. J. & Nixon, R. A. Disorders of lysosomal acidification \u2014 The emerging role of v-ATPase in aging and neurodegenerative disease. Ageing Res. Rev. 32, 75\u201388 (2016).","journal-title":"Ageing Res. Rev."},{"key":"BFnrd2018109_CR41","doi-asserted-by":"crossref","first-page":"7007","DOI":"10.1038\/ncomms8007","volume":"6","author":"C Mauvezin","year":"2015","unstructured":"Mauvezin, C., Nagy, P., Juhasz, G. & Neufeld, T. P. Autophagosome-lysosome fusion is independent of V-ATPase-mediated acidification. Nat. Commun. 6, 7007 (2015).","journal-title":"Nat. Commun."},{"key":"BFnrd2018109_CR42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/9781118978320.ch14","volume-title":"Lysosomes: Biology, Diseases, and Therapeutics","author":"S Lu","year":"2016","unstructured":"Lu, S. & Nixon, R. A. in Lysosomes: Biology, Diseases, and Therapeutics 315\u2013356 (John Wiley & Sons, 2016)."},{"key":"BFnrd2018109_CR43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrd.2017.214","volume":"17","author":"FM Platt","year":"2017","unstructured":"Platt, F. M. Emptying the stores: lysosomal diseases and therapeutic strategies. Nat. Rev. Drug Discov. 17, 133\u2013150 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnrd2018109_CR44","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3565","volume":"14","author":"C Settembre","year":"2013","unstructured":"Settembre, C., Fraldi, A., Medina, D. L. & Ballabio, A. Signals from the lysosome: a control centre for cellular clearance and energy metabolism. Nat. Rev. Mol. Cell Biol. 14, 283\u2013296 (2013).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnrd2018109_CR45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mcn.2015.01.003","volume":"66","author":"M Xilouri","year":"2015","unstructured":"Xilouri, M. & Stefanis, L. Chaperone mediated autophagy to the rescue: A new-fangled target for the treatment of neurodegenerative diseases. Mol. Cell Neurosci. 66, 29\u201336 (2015).","journal-title":"Mol. Cell Neurosci."},{"key":"BFnrd2018109_CR46","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1042\/EBC20170057","volume":"61","author":"S Catarino","year":"2017","unstructured":"Catarino, S., Pereira, P. & Girao, H. Molecular control of chaperone-mediated autophagy. Essays Biochem. 61, 663\u2013674 (2017).","journal-title":"Essays Biochem."},{"key":"BFnrd2018109_CR47","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41580-018-0001-6","volume":"19","author":"S Kaushik","year":"2018","unstructured":"Kaushik, S. & Cuervo, A. M. The coming of age of chaperone-mediated autophagy. Nat. Rev. Mol. Cell Biol. 19, 365\u2013381 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnrd2018109_CR48","doi-asserted-by":"crossref","first-page":"R91","DOI":"10.1093\/hmg\/ddx274","volume":"26","author":"DB Medinas","year":"2017","unstructured":"Medinas, D. B., Valenzuela, V. & Hetz, C. Proteostasis disturbance in amyotrophic lateral sclerosis. Hum. Mol. Genet. 26, R91\u2013R104 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrd2018109_CR49","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1016\/j.jmb.2017.09.015","volume":"429","author":"SAH de Poot","year":"2017","unstructured":"de Poot, S. A. H., Tian, G. & Finley, D. Meddling with fate: the proteasomal deubiquitinating enzymes. J. Mol. Biol. 429, 3525\u20133545 (2017).","journal-title":"J. Mol. Biol."},{"key":"BFnrd2018109_CR50","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1089\/ars.2016.6802","volume":"25","author":"V Bonet-Costa","year":"2016","unstructured":"Bonet-Costa, V., Pomatto, L. C. & Davies, K. J. The proteasome and oxidative stress in Alzheimer's disease. Antioxid. Redox Signal 25, 886\u2013901 (2016).","journal-title":"Antioxid. Redox Signal"},{"key":"BFnrd2018109_CR51","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nature14951","volume":"524","author":"L Wrobel","year":"2015","unstructured":"Wrobel, L. et al. Mistargeted mitochondrial proteins activate a proteostatic response in the cytosol. Nature 524, 485\u2013488 (2015).","journal-title":"Nature"},{"key":"BFnrd2018109_CR52","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.nlm.2016.09.003","volume":"138","author":"AN Hegde","year":"2017","unstructured":"Hegde, A. N. Proteolysis, synaptic plasticity and memory. Neurobiol. Learn. Mem. 138, 98\u2013110 (2017).","journal-title":"Neurobiol. Learn. Mem."},{"key":"BFnrd2018109_CR53","doi-asserted-by":"crossref","first-page":"e95914","DOI":"10.1371\/journal.pone.0095914","volume":"9","author":"KJ Wolfe","year":"2014","unstructured":"Wolfe, K. J., Ren, H. Y., Trepte, P. & Cyr, D. M. Polyglutamine-rich suppressors of huntingtin toxicity act upstream of Hsp70 and Sti1 in spatial quality control of amyloid-like proteins. PLoS One 9, e95914 (2014).","journal-title":"PLoS One"},{"key":"BFnrd2018109_CR54","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/cdd.2014.151","volume":"22","author":"FM Menzies","year":"2015","unstructured":"Menzies, F. M. et al. Calpain inhibition mediates autophagy-dependent protection against polyglutamine toxicity. Cell Death Differ. 22, 433\u2013444 (2015).","journal-title":"Cell Death Differ."},{"key":"BFnrd2018109_CR55","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1038\/emm.2014.117","volume":"47","author":"A Ciechanover","year":"2015","unstructured":"Ciechanover, A. & Kwon, Y. T. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies. Exp. Mol. Med. 47, e147 (2015).","journal-title":"Exp. Mol. Med."},{"key":"BFnrd2018109_CR56","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1038\/ncomms6659","volume":"5","author":"D Vilchez","year":"2014","unstructured":"Vilchez, D., Saez, I. & Dillin, A. The role of protein clearance mechanisms in organismal ageing and age-related diseases. Nat. Commun. 5, 5659 (2014).","journal-title":"Nat. Commun."},{"key":"BFnrd2018109_CR57","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.brainres.2016.02.033","volume":"1648","author":"B Mollereau","year":"2016","unstructured":"Mollereau, B. et al. Adaptive preconditioning in neurological diseases \u2013 therapeutic insights from proteostatic perturbations. Brain Res. 1648, 603\u2013616 (2016).","journal-title":"Brain Res."},{"key":"BFnrd2018109_CR58","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature25143","volume":"552","author":"V Sorrentino","year":"2017","unstructured":"Sorrentino, V. et al. Enhancing mitochondrial proteostasis reduces amyloid-\u03b2 proteotoxicity. Nature 552, 187\u2013193 (2017).","journal-title":"Nature"},{"key":"BFnrd2018109_CR59","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cell.2016.12.044","volume":"168","author":"YA Huang","year":"2017","unstructured":"Huang, Y. A., Zhou, B., Wernig, M. & Sudhof, T. C. ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and A\u03b2 secretion. Cell 168, 427\u2013441.e21 (2017).","journal-title":"Cell"},{"key":"BFnrd2018109_CR60","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/jamaneurol.2013.2152","volume":"70","author":"BV Zlokovic","year":"2013","unstructured":"Zlokovic, B. V. Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease. JAMA Neurol. 70, 440\u2013444 (2013).","journal-title":"JAMA Neurol."},{"key":"BFnrd2018109_CR61","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1080\/14728222.2016.1182990","volume":"20","author":"Z Zhang","year":"2016","unstructured":"Zhang, Z., Xie, M. & Ye, K. Asparagine endopeptidase is an innovative therapeutic target for neurodegenerative diseases. Expert Opin. Ther. Targets 20, 1237\u20131245 (2016).","journal-title":"Expert Opin. Ther. Targets"},{"key":"BFnrd2018109_CR62","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3233\/JAD-151101","volume":"51","author":"S Simonovitch","year":"2016","unstructured":"Simonovitch, S. et al. Impaired autophagy in APOE4 astrocytes. J. Alzheimers Dis. 51, 915\u2013927 (2016).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrd2018109_CR63","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.cell.2010.05.008","volume":"141","author":"JH Lee","year":"2010","unstructured":"Lee, J. H. et al. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 141, 1146\u20131158 (2010).","journal-title":"Cell"},{"key":"BFnrd2018109_CR64","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3389\/fnmol.2017.00291","volume":"10","author":"P Martin-Maestro","year":"2017","unstructured":"Martin-Maestro, P. et al. Mitophagy failure in fibroblasts and iPSC-derived neurons of Alzheimer's disease-associated presenilin 1 mutation. Front. Mol. Neurosci. 10, 291 (2017).","journal-title":"Front. Mol. Neurosci."},{"key":"BFnrd2018109_CR65","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.cell.2016.05.020","volume":"166","author":"R Sannerud","year":"2016","unstructured":"Sannerud, R. et al. Restricted location of PSEN2\/\u03b3-secretase determines substrate specificity and generates an intracellular A\u03b2 pool. Cell 166, 193\u2013208 (2016).","journal-title":"Cell"},{"key":"BFnrd2018109_CR66","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00401-016-1577-6","volume":"132","author":"I Lauritzen","year":"2016","unstructured":"Lauritzen, I. et al. Intraneuronal aggregation of the \u03b2-CTF fragment of APP (C99) induces A\u03b2-independent lysosomal-autophagic pathology. Acta Neuropathol. 132, 257\u2013276 (2016).","journal-title":"Acta Neuropathol."},{"key":"BFnrd2018109_CR67","doi-asserted-by":"crossref","first-page":"7395","DOI":"10.1074\/jbc.M116.753525","volume":"292","author":"GS Seixas da Silva","year":"2017","unstructured":"Seixas da Silva, G. S. et al. Amyloid-\u03b2 oligomers transiently inhibit AMP-activated kinase and cause metabolic defects in hippocampal neurons. J. Biol. Chem. 292, 7395\u20137406 (2017).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2018109_CR68","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.molmed.2017.11.006","volume":"24","author":"N Myeku","year":"2018","unstructured":"Myeku, N. & Duff, K. Targeting the 26S proteasome to protect against proteotoxic diseases. Trends Mol. Med. 24, 15\u201329 (2018).","journal-title":"Trends Mol. Med."},{"key":"BFnrd2018109_CR69","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1152\/physrev.00022.2010","volume":"91","author":"O Corti","year":"2011","unstructured":"Corti, O., Lesage, S. & Brice, A. What genetics tells us about the cause and mechanisms of Parkinson's disease: Physiol. Rev. Transm. Suppl. 91, 1161\u20131128 (2011).","journal-title":"Physiol. Rev. Transm. Suppl."},{"key":"BFnrd2018109_CR70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrm3028","volume":"12","author":"RJ Youle","year":"2011","unstructured":"Youle, R. J. & Narendra, D. P. Mechanisms of mitophagy. Nat. Rev. Mol. Cell Biol. 12, 9\u201314 (2011).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnrd2018109_CR71","doi-asserted-by":"crossref","first-page":"eaam6790","DOI":"10.1126\/scisignal.aam6790","volume":"10","author":"ZC Chen","year":"2017","unstructured":"Chen, Z. C. et al. Phosphorylation of amyloid precursor protein by mutant LRRK2 promotes AICD activity and neurotoxicity in Parkinson's disease. Sci. Signal. 10, eaam6790 (2017).","journal-title":"Sci. Signal."},{"key":"BFnrd2018109_CR72","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.neuron.2017.09.036","volume":"96","author":"E Giaime","year":"2017","unstructured":"Giaime, E. et al. Age-dependent dopaminergic neurodegeneration and impairment of the autophagy-lysosomal pathway in LRRK-deficient mice. Neuron 96, 796\u2013807.e6 (2017).","journal-title":"Neuron"},{"key":"BFnrd2018109_CR73","doi-asserted-by":"crossref","first-page":"35106","DOI":"10.1038\/srep35106","volume":"6","author":"C Manzoni","year":"2016","unstructured":"Manzoni, C. et al. mTOR independent regulation of macroautophagy by Leucine Rich Repeat Kinase 2 via Beclin-1. Sci. Rep. 6, 35106 (2016).","journal-title":"Sci. Rep."},{"key":"BFnrd2018109_CR74","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.neuron.2017.01.018","volume":"93","author":"E Aflaki","year":"2017","unstructured":"Aflaki, E., Westbroek, W. & Sidransky, E. The complicated relationship between Gaucher Disease and parkinsonism: insights from a rare disease. Neuron 93, 737\u2013746 (2017).","journal-title":"Neuron"},{"key":"BFnrd2018109_CR75","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jns.2015.06.030","volume":"356","author":"C Noelker","year":"2015","unstructured":"Noelker, C. et al. Glucocerebrosidase deficiency and mitochondrial impairment in experimental Parkinson disease. J. Neurol. Sci. 356, 129\u2013136 (2015).","journal-title":"J. Neurol. Sci."},{"key":"BFnrd2018109_CR76","doi-asserted-by":"crossref","first-page":"11803","DOI":"10.1038\/ncomms11803","volume":"7","author":"CF Bento","year":"2016","unstructured":"Bento, C. F., Ashkenazi, A., Jimenez-Sanchez, M. & Rubinsztein, D. C. The Parkinson's disease-associated genes ATP13A2 and SYT11 regulate autophagy via a common pathway. Nat. Commun. 7, 11803 (2016).","journal-title":"Nat. Commun."},{"key":"BFnrd2018109_CR77","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1093\/hmg\/ddu099","volume":"23","author":"SM Kong","year":"2014","unstructured":"Kong, S. M. et al. Parkinson's disease-linked human PARK9\/ATP13A2 maintains zinc homeostasis and promotes \u03b1-synuclein externalization via exosomes. Hum. Mol. Genet. 23, 2816\u20132833 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrd2018109_CR78","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1093\/hmg\/ddt572","volume":"23","author":"T Tsunemi","year":"2014","unstructured":"Tsunemi, T. & Krainc, D. Zn2+ dyshomeostasis caused by loss of ATP13A2\/PARK9 leads to lysosomal dysfunction and \u03b1-synuclein accumulation. Hum. Mol. Genet. 23, 2791\u20132801 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrd2018109_CR79","doi-asserted-by":"crossref","first-page":"e0184040","DOI":"10.1371\/journal.pone.0184040","volume":"12","author":"L Zondler","year":"2017","unstructured":"Zondler, L. et al. Proteasome impairment by \u03b1-synuclein. PLOS One 12, e0184040 (2017).","journal-title":"PLOS One"},{"key":"BFnrd2018109_CR80","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fnmol.2016.00157","volume":"9","author":"G Sala","year":"2016","unstructured":"Sala, G., Marinig, D., Arosio, A. & Ferrarese, C. Role of chaperone-mediated autophagy dysfunctions in the pathogenesis of Parkinson's disease. Front. Mol. Neurosci. 9, 157 (2016).","journal-title":"Front. Mol. Neurosci."},{"key":"BFnrd2018109_CR81","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nrd.2017.155","volume":"16","author":"C Li","year":"2017","unstructured":"Li, C. & Gotz, J. Tau-based therapies in neurodegeneration: opportunities and challenges. Nat. Rev. Drug Discov. 16, 863\u2013883 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnrd2018109_CR82","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.15252\/embj.201797568","volume":"36","author":"FB Gao","year":"2017","unstructured":"Gao, F. B., Almeida, S. & Lopez-Gonzalez, R. Dysregulated molecular pathways in amyotrophic lateral sclerosis-frontotemporal dementia spectrum disorder. EMBO J. 36, 2931\u20132950 (2017).","journal-title":"EMBO J."},{"key":"BFnrd2018109_CR83","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.arr.2016.04.008","volume":"32","author":"JK Gotzl","year":"2016","unstructured":"Gotzl, J. K., Lang, C. M., Haass, C. & Capell, A. Impaired protein degradation in FTLD and related disorders. Ageing Res. Rev. 32, 122\u2013139 (2016).","journal-title":"Ageing Res. Rev."},{"key":"BFnrd2018109_CR84","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3389\/fnmol.2017.00263","volume":"10","author":"N Ramesh","year":"2017","unstructured":"Ramesh, N. & Pandey, U. B. Autophagy dysregulation in ALS: when protein aggregates get out of hand. Front. Mol. Neurosci. 10, 263 (2017).","journal-title":"Front. Mol. Neurosci."},{"key":"BFnrd2018109_CR85","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.cell.2017.12.030","volume":"172","author":"Q Guo","year":"2018","unstructured":"Guo, Q. et al. In situ structure of neuronal C9orf72 poly-GA aggregates reveals proteasome recruitment. Cell 172, 696\u2013705.e12 (2018).","journal-title":"Cell"},{"key":"BFnrd2018109_CR86","first-page":"969","volume":"26","author":"Y Tanaka","year":"2017","unstructured":"Tanaka, Y. et al. Progranulin regulates lysosomal function and biogenesis through acidification of lysosomes. Hum. Mol. Genet. 26, 969\u2013988 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrd2018109_CR87","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13041-017-0287-x","volume":"10","author":"JA Oakes","year":"2017","unstructured":"Oakes, J. A., Davies, M. C. & Collins, M. O. TBK1: a new player in ALS linking autophagy and neuroinflammation. Mol. Brain 10, 5 (2017).","journal-title":"Mol. Brain"},{"key":"BFnrd2018109_CR88","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3389\/fnins.2017.00442","volume":"11","author":"M Nassif","year":"2017","unstructured":"Nassif, M., Woehlbier, U. & Manque, P. A. The enigmatic role of C9ORF72 in autophagy. Front. Neurosci. 11, 442 (2017).","journal-title":"Front. Neurosci."},{"key":"BFnrd2018109_CR89","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1080\/15548627.2017.1299312","volume":"13","author":"YJ Ji","year":"2017","unstructured":"Ji, Y. J., Ugolino, J., Brady, N. R., Hamacher-Brady, A. & Wang, J. Systemic deregulation of autophagy upon loss of ALS- and FTD-linked C9orf72. Autophagy 13, 1254\u20131255 (2017).","journal-title":"Autophagy"},{"key":"BFnrd2018109_CR90","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1038\/s41598-017-05313-0","volume":"7","author":"A Henriques","year":"2017","unstructured":"Henriques, A. et al. Inhibition of \u03b2-glucocerebrosidase activity preserves motor unit integrity in a mouse model of amyotrophic lateral sclerosis. Sci. Rep. 7, 5235 (2017).","journal-title":"Sci. Rep."},{"key":"BFnrd2018109_CR91","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/bs.ctdb.2016.07.004","volume":"121","author":"G Lin","year":"2017","unstructured":"Lin, G., Mao, D. & Bellen, H. J. Amyotrophic lateral sclerosis pathogenesis converges on defects in protein homeostasis associated with TDP-43 mislocalization and proteasome-mediated degradation overload. Curr. Top. Dev. Biol. 121, 111\u2013171 (2017).","journal-title":"Curr. Top. Dev. Biol."},{"key":"BFnrd2018109_CR92","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/cdd.2015.80","volume":"22","author":"M Kaliszewski","year":"2015","unstructured":"Kaliszewski, M., Knott, A. B. & Bossy-Wetzel, E. Primary cilia and autophagic dysfunction in Huntington's disease. Cell Death Differ. 22, 1413\u20131424 (2015).","journal-title":"Cell Death Differ."},{"key":"BFnrd2018109_CR93","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1074\/jbc.M113.536912","volume":"289","author":"RG Mealer","year":"2014","unstructured":"Mealer, R. G., Murray, A. J., Shahani, N., Subramaniam, S. & Snyder, S. H. Rhes, a striatal-selective protein implicated in Huntington disease, binds beclin-1 and activates autophagy. J. Biol. Chem. 289, 3547\u20133554 (2014).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2018109_CR94","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature22078","volume":"545","author":"A Ashkenazi","year":"2017","unstructured":"Ashkenazi, A. et al. Polyglutamine tracts regulate beclin 1-dependent autophagy. Nature 545, 118\u2013111 (2017).","journal-title":"Nature"},{"key":"BFnrd2018109_CR95","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nbt.1608","volume":"28","author":"PO Bauer","year":"2010","unstructured":"Bauer, P. O. et al. Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein. Nat. Biotechnol. 28, 256\u2013263 (2010).","journal-title":"Nat. Biotechnol."},{"key":"BFnrd2018109_CR96","doi-asserted-by":"crossref","first-page":"e5515","DOI":"10.1371\/journal.pone.0005515","volume":"4","author":"M Xilouri","year":"2009","unstructured":"Xilouri, M., Vogiatzi, T., Vekrellis, K., Park, D. & Stefanis, L. Abberant \u03b1-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PLoS One 4, e5515 (2009).","journal-title":"PLoS One"},{"key":"BFnrd2018109_CR97","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/bpa.12191","volume":"25","author":"LS Her","year":"2015","unstructured":"Her, L. S. et al. The differential profiling of ubiquitin-proteasome and autophagy systems in different tissues before the onset of Huntington's disease models. Brain Pathol. 25, 481\u2013490 (2015).","journal-title":"Brain Pathol."},{"key":"BFnrd2018109_CR98","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.15252\/embr.201642195","volume":"17","author":"K Pakos-Zebrucka","year":"2016","unstructured":"Pakos-Zebrucka, K. et al. The integrated stress response. EMBO Rep. 17, 1374\u20131395 (2016).","journal-title":"EMBO Rep."},{"key":"BFnrd2018109_CR99","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/brain\/awx074","volume":"140","author":"M Halliday","year":"2017","unstructured":"Halliday, M. et al. Repurposed drugs targeting eIF2\u03b1-P-mediated translational repression prevent neurodegeneration in mice. Brain 140, 1768\u20131773 (2017).","journal-title":"Brain"},{"key":"BFnrd2018109_CR100","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2018.01.004","volume":"69","author":"A Mogk","year":"2018","unstructured":"Mogk, A., Bukau, B. & Kampinga, H. H. Cellular handling of protein aggregates by disaggregation machines. Mol. Cell 69, 214\u2013226 (2018).","journal-title":"Mol. Cell"},{"key":"BFnrd2018109_CR101","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4161\/auto.19048","volume":"8","author":"EE Congdon","year":"2012","unstructured":"Congdon, E. E. et al. Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo. Autophagy 8, 609\u2013622 (2012).","journal-title":"Autophagy"},{"key":"BFnrd2018109_CR102","first-page":"56","volume":"7","author":"L Xie","year":"2013","unstructured":"Xie, L. et al. Methylene blue induces macroautophagy through 5\u2032 adenosine monophosphate-activated protein kinase pathway to protect neurons from serum deprivation. Front. Cell Neurosci. 7, 56 (2013).","journal-title":"Front. Cell Neurosci."},{"key":"BFnrd2018109_CR103","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nchembio.79","volume":"4","author":"A Williams","year":"2008","unstructured":"Williams, A. et al. Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nat. Chem. Biol. 4, 295\u2013305 (2008).","journal-title":"Nat. Chem. Biol."},{"key":"BFnrd2018109_CR104","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/hmg\/ddq093","volume":"19","author":"C Rose","year":"2010","unstructured":"Rose, C. et al. Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease. Hum. Mol. Genet. 19, 2144\u20132153 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrd2018109_CR105","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/cdd.2008.110","volume":"16","author":"S Sarkar","year":"2009","unstructured":"Sarkar, S., Ravikumar, B., Floto, R. A. & Rubinsztein, D. C. Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies. Cell Death Differ. 16, 46\u201356 (2009).","journal-title":"Cell Death Differ."},{"key":"BFnrd2018109_CR106","doi-asserted-by":"crossref","first-page":"9222","DOI":"10.1523\/JNEUROSCI.1132-14.2014","volume":"34","author":"MV Rao","year":"2014","unstructured":"Rao, M. V. et al. Specific calpain inhibition by calpastatin prevents tauopathy and neurodegeneration and restores normal lifespan in tau P301L mice. J. Neurosci. 34, 9222\u20139234 (2014).","journal-title":"J. Neurosci."},{"key":"BFnrd2018109_CR107","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/jnc.13536","volume":"137","author":"MV Rao","year":"2016","unstructured":"Rao, M. V., Campbell, J., Palaniappan, A., Kumar, A. & Nixon, R. A. Calpastatin inhibits motor neuron death and increases survival of hSOD1(G93A) mice. J. Neurochem. 137, 253\u2013265 (2016).","journal-title":"J. Neurochem."},{"key":"BFnrd2018109_CR108","doi-asserted-by":"crossref","first-page":"e0160620","DOI":"10.1371\/journal.pone.0160620","volume":"11","author":"SY Park","year":"2016","unstructured":"Park, S. Y. et al. Cilostazol modulates autophagic degradation of \u03b2-amyloid peptide via SIRT1-coupled LKB1\/AMPK\u03b1 signaling in neuronal cells. PLOS One 11, e0160620 (2016).","journal-title":"PLOS One"},{"key":"BFnrd2018109_CR109","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1742-2094-2-21","volume":"2","author":"KR Ayasolla","year":"2005","unstructured":"Ayasolla, K. R., Singh, A. K. & Singh, I. 5-Aminoimidazole-4-carboxamide-1-\u03b2-4-ribofuranoside (AICAR) attenuates the expression of LPS- and A\u03b2 peptide-induced inflammatory mediators in astroglia. J. Neuroinflamm. 2, 21 (2005).","journal-title":"J. Neuroinflamm."},{"key":"BFnrd2018109_CR110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2013.11.002","volume":"63","author":"M Dulovic","year":"2014","unstructured":"Dulovic, M. et al. The protective role of AMP-activated protein kinase in \u03b1-synuclein neurotoxicity in vitro. Neurobiol. Dis. 63, 1\u201311 (2014).","journal-title":"Neurobiol. Dis."},{"key":"BFnrd2018109_CR111","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuropharm.2016.04.041","volume":"108","author":"C Walter","year":"2016","unstructured":"Walter, C. et al. Activation of AMPK-induced autophagy ameliorates Huntington disease pathology in vitro. Neuropharmacology 108, 24\u201338 (2016).","journal-title":"Neuropharmacology"},{"key":"BFnrd2018109_CR112","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1523\/JNEUROSCI.3229-16.2017","volume":"37","author":"ZH Zhang","year":"2017","unstructured":"Zhang, Z. H. et al. Selenomethionine mitigates cognitive decline by targeting both Tau hyperphosphorylation and autophagic clearance in an Alzheimer's disease mouse model. J. Neurosci. 37, 2449\u20132462 (2017).","journal-title":"J. Neurosci."},{"key":"BFnrd2018109_CR113","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.cell.2012.01.017","volume":"148","author":"SJ Park","year":"2012","unstructured":"Park, S. J. et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148, 421\u2013433 (2012).","journal-title":"Cell"},{"key":"BFnrd2018109_CR114","doi-asserted-by":"crossref","first-page":"9100","DOI":"10.1074\/jbc.M109.060061","volume":"285","author":"V Vingtdeux","year":"2010","unstructured":"Vingtdeux, V. et al. AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-\u03b2 peptide metabolism. J. Biol. Chem. 285, 9100\u20139113 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2018109_CR115","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/ng1534","volume":"37","author":"JA Parker","year":"2005","unstructured":"Parker, J. A. et al. Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat. Genet. 37, 349\u2013350 (2005).","journal-title":"Nat. Genet."},{"key":"BFnrd2018109_CR116","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/ncomms3192","volume":"4","author":"A Martin-Montalvo","year":"2013","unstructured":"Martin-Montalvo, A. et al. Metformin improves healthspan and lifespan in mice. Nat. Commun. 4, 2192 (2013).","journal-title":"Nat. Commun."},{"key":"BFnrd2018109_CR117","doi-asserted-by":"crossref","first-page":"21830","DOI":"10.1073\/pnas.0912793107","volume":"107","author":"E Kickstein","year":"2010","unstructured":"Kickstein, E. et al. Biguanide metformin acts on tau phosphorylation via mTOR\/protein phosphatase 2A (PP2A) signaling. Proc. Natl Acad. Sci. USA 107, 21830\u201321835 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2018109_CR118","first-page":"1421430","volume":"2016","author":"B Chen","year":"2016","unstructured":"Chen, B., Teng, Y., Zhang, X., Lv, X. & Yin, Y. Metformin alleviated A\u03b2-induced apoptosis via the suppression of JNK MAPK signaling pathway in cultured hippocampal neurons. Biomed. Res. Int. 2016, 1421430 (2016).","journal-title":"Biomed. Res. Int."},{"key":"BFnrd2018109_CR119","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.neuroscience.2014.07.046","volume":"277","author":"SP Patil","year":"2014","unstructured":"Patil, S. P., Jain, P. D., Ghumatkar, P. J., Tambe, R. & Sathaye, S. Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice. Neuroscience 277, 747\u2013754 (2014).","journal-title":"Neuroscience"},{"key":"BFnrd2018109_CR120","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.4161\/auto.25188","volume":"9","author":"K Castillo","year":"2013","unstructured":"Castillo, K. et al. Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons. Autophagy 9, 1308\u20131320 (2013).","journal-title":"Autophagy"},{"key":"BFnrd2018109_CR121","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1074\/jbc.M609532200","volume":"282","author":"S Sarkar","year":"2007","unstructured":"Sarkar, S., Davies, J. E., Huang, Z., Tunnacliffe, A. & Rubinsztein, D. C. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and \u03b1-synuclein. J. Biol. Chem. 282, 5641\u20135652 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2018109_CR122","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.neurobiolaging.2011.11.009","volume":"33","author":"U Kruger","year":"2012","unstructured":"Kruger, U., Wang, Y., Kumar, S. & Mandelkow, E. M. Autophagic degradation of tau in primary neurons and its enhancement by trehalose. Neurobiol. Aging 33, 2291\u20132305 (2012).","journal-title":"Neurobiol. Aging"},{"key":"BFnrd2018109_CR123","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1111\/jphp.12108","volume":"65","author":"J Du","year":"2013","unstructured":"Du, J., Liang, Y., Xu, F., Sun, B. & Wang, Z. Trehalose rescues Alzheimer's disease phenotypes in APP\/PS1 transgenic mice. J. Pharm. Pharmacol. 65, 1753\u20131756 (2013).","journal-title":"J. Pharm. Pharmacol."},{"key":"BFnrd2018109_CR124","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nm985","volume":"10","author":"M Tanaka","year":"2004","unstructured":"Tanaka, M. et al. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nat. Med. 10, 148\u2013154 (2004).","journal-title":"Nat. Med."},{"key":"BFnrd2018109_CR125","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.4161\/auto.21488","volume":"8","author":"V Schaeffer","year":"2012","unstructured":"Schaeffer, V. & Goedert, M. Stimulation of autophagy is neuroprotective in a mouse model of human tauopathy. Autophagy 8, 1686\u20131687 (2012).","journal-title":"Autophagy"},{"key":"BFnrd2018109_CR126","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1083\/jcb.200504035","volume":"170","author":"S Sarkar","year":"2005","unstructured":"Sarkar, S. et al. Lithium induces autophagy by inhibiting inositol monophosphatase. J. Cell Biol. 170, 1101\u20131111 (2005).","journal-title":"J. Cell Biol."},{"key":"BFnrd2018109_CR127","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.nbd.2011.12.050","volume":"46","author":"K Shimada","year":"2012","unstructured":"Shimada, K. et al. Long-term oral lithium treatment attenuates motor disturbance in tauopathy model mice: implications of autophagy promotion. Neurobiol. Dis. 46, 101\u2013108 (2012).","journal-title":"Neurobiol. Dis."},{"key":"BFnrd2018109_CR128","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1073\/pnas.0708022105","volume":"105","author":"F Fornai","year":"2008","unstructured":"Fornai, F. et al. Lithium delays progression of amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 105, 2052\u20132057 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2018109_CR129","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/WNR.0000000000000401","volume":"26","author":"H Li","year":"2015","unstructured":"Li, H. et al. Biochemical protective effect of 1,25-dihydroxyvitamin D3 through autophagy induction in the MPTP mouse model of Parkinson's disease. Neuroreport 26, 669\u2013674 (2015).","journal-title":"Neuroreport"},{"key":"BFnrd2018109_CR130","doi-asserted-by":"crossref","first-page":"25009","DOI":"10.1074\/jbc.M300227200","volume":"278","author":"JL Webb","year":"2003","unstructured":"Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N. & Rubinsztein, D. C. \u03b1-Synuclein is degraded by both autophagy and the proteasome. J. Biol. Chem. 278, 25009\u201325013 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2018109_CR131","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/hmg\/11.9.1107","volume":"11","author":"B Ravikumar","year":"2002","unstructured":"Ravikumar, B., Duden, R. & Rubinsztein, D. C. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum. Mol. Genet. 11, 1107\u20131117 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrd2018109_CR132","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1016\/j.neurobiolaging.2014.07.026","volume":"35","author":"HH Ryu","year":"2014","unstructured":"Ryu, H. H. et al. Autophagy regulates amyotrophic lateral sclerosis-linked fused in sarcoma-positive stress granules in neurons. Neurobiol. Aging 35, 2822\u20132831 (2014).","journal-title":"Neurobiol. Aging"},{"key":"BFnrd2018109_CR133","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","volume":"36","author":"B Ravikumar","year":"2004","unstructured":"Ravikumar, B. et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 36, 585\u2013595 (2004).","journal-title":"Nat. Genet."},{"key":"BFnrd2018109_CR134","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4161\/auto.22526","volume":"9","author":"IF Wang","year":"2013","unstructured":"Wang, I. F., Tsai, K. J. & Shen, C. K. Autophagy activation ameliorates neuronal pathogenesis of FTLD-U mice: a new light for treatment of TARDBP\/TDP-43 proteinopathies. Autophagy 9, 239\u2013240 (2013).","journal-title":"Autophagy"},{"key":"BFnrd2018109_CR135","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11064-012-0909-8","volume":"38","author":"K Liu","year":"2013","unstructured":"Liu, K., Shi, N., Sun, Y., Zhang, T. & Sun, X. Therapeutic effects of rapamycin on MPTP-induced parkinsonism in mice. Neurochem. Res. 38, 201\u2013207 (2013).","journal-title":"Neurochem. Res."},{"key":"BFnrd2018109_CR136","doi-asserted-by":"crossref","first-page":"13107","DOI":"10.1074\/jbc.M110.100420","volume":"285","author":"A Caccamo","year":"2010","unstructured":"Caccamo, A., Majumder, S., Richardson, A., Strong, R. & Oddo, S. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-\u03b2, and Tau: effects on cognitive impairments. J. Biol. Chem. 285, 13107\u201313120 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2018109_CR137","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuropharm.2014.05.032","volume":"85","author":"T Jiang","year":"2014","unstructured":"Jiang, T. et al. Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance. Neuropharmacology 85, 121\u2013130 (2014).","journal-title":"Neuropharmacology"},{"key":"BFnrd2018109_CR138","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s12035-017-0496-4","volume":"55","author":"R Siracusa","year":"2017","unstructured":"Siracusa, R. et al. Neuroprotective effects of temsirolimus in animal models of Parkinson's disease. Mol. Neurobiol. 55, 2403\u20132419 (2017).","journal-title":"Mol. Neurobiol."},{"key":"BFnrd2018109_CR139","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/brain\/awp292","volume":"133","author":"FM Menzies","year":"2010","unstructured":"Menzies, F. M. et al. Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3. Brain 133, 93\u2013104 (2010).","journal-title":"Brain"},{"key":"BFnrd2018109_CR140","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nchembio883","volume":"3","author":"S Sarkar","year":"2007","unstructured":"Sarkar, S. et al. Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat. Chem. Biol. 3, 331\u2013338 (2007).","journal-title":"Nat. Chem. Biol."},{"key":"BFnrd2018109_CR141","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tiv.2015.09.006","volume":"30","author":"V Satish Bollimpelli","year":"2015","unstructured":"Satish Bollimpelli, V. & Kondapi, A. K. Differential sensitivity of immature and mature ventral mesencephalic neurons to rotenone induced neurotoxicity in vitro. Toxicol. In Vitro 30, 545\u2013551 (2015).","journal-title":"Toxicol. In Vitro"},{"key":"BFnrd2018109_CR142","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00401-007-0332-4","volume":"115","author":"N Pandey","year":"2008","unstructured":"Pandey, N., Strider, J., Nolan, W. C., Yan, S. X. & Galvin, J. E. Curcumin inhibits aggregation of \u03b1-synuclein. Acta Neuropathol. 115, 479\u2013489 (2008).","journal-title":"Acta Neuropathol."},{"key":"BFnrd2018109_CR143","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11481-012-9431-7","volume":"8","author":"TF Jiang","year":"2013","unstructured":"Jiang, T. F. et al. Curcumin ameliorates the neurodegenerative pathology in A53T \u03b1-synuclein cell model of Parkinson's disease through the downregulation of mTOR\/p70S6K signaling and the recovery of macroautophagy. J. Neuroimmune Pharmacol. 8, 356\u2013369 (2013).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"BFnrd2018109_CR144","doi-asserted-by":"crossref","first-page":"e0128510","DOI":"10.1371\/journal.pone.0128510","volume":"10","author":"KJ Spinelli","year":"2015","unstructured":"Spinelli, K. J., Osterberg, V. R., Meshul, C. K., Soumyanath, A. & Unni, V. K. Curcumin treatment improves motor behavior in \u03b1-synuclein transgenic mice. PLoS One 10, e0128510 (2015).","journal-title":"PLoS One"},{"key":"BFnrd2018109_CR145","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1074\/jbc.M112.393751","volume":"288","author":"QL Ma","year":"2013","unstructured":"Ma, Q. L. et al. Curcumin suppresses soluble tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits in aged human tau transgenic mice. J. Biol. Chem. 288, 4056\u20134065 (2013).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2018109_CR146","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","volume":"280","author":"F Yang","year":"2005","unstructured":"Yang, F. et al. Curcumin inhibits formation of amyloid \u03b2 oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 280, 5892\u20135901 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2018109_CR147","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/ncb3114","volume":"17","author":"DL Medina","year":"2015","unstructured":"Medina, D. L. et al. Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nat. Cell Biol. 17, 288\u2013299 (2015).","journal-title":"Nat. Cell Biol."},{"key":"BFnrd2018109_CR148","doi-asserted-by":"crossref","first-page":"12137","DOI":"10.1523\/JNEUROSCI.0705-15.2015","volume":"35","author":"Q Xiao","year":"2015","unstructured":"Xiao, Q. et al. Neuronal-targeted TFEB accelerates lysosomal degradation of APP, reducing A\u03b2 generation and amyloid plaque pathogenesis. J. Neurosci. 35, 12137\u201312151 (2015).","journal-title":"J. Neurosci."},{"key":"BFnrd2018109_CR149","doi-asserted-by":"crossref","first-page":"24933","DOI":"10.1038\/srep24933","volume":"6","author":"S Kim","year":"2016","unstructured":"Kim, S. et al. Fisetin stimulates autophagic degradation of phosphorylated tau via the activation of TFEB and Nrf2 transcription factors. Sci. Rep. 6, 24933 (2016).","journal-title":"Sci. Rep."},{"key":"BFnrd2018109_CR150","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1074\/jbc.M114.586602","volume":"290","author":"Y Hori","year":"2015","unstructured":"Hori, Y. et al. A Food and Drug Administration-approved asthma therapeutic agent impacts amyloid \u03b2 in the brain in a transgenic model of Alzheimer disease. J. Biol. Chem. 290, 1966\u20131978 (2015).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2018109_CR151","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ncb3407","volume":"18","author":"Y Li","year":"2016","unstructured":"Li, Y. et al. Protein kinase C controls lysosome biogenesis independently of mTORC1. Nat. Cell Biol. 18, 1065\u20131077 (2016).","journal-title":"Nat. Cell Biol."},{"key":"BFnrd2018109_CR152","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s12031-011-9588-1","volume":"45","author":"SD Schlatterer","year":"2011","unstructured":"Schlatterer, S. D., Acker, C. M. & Davies, P. c-Abl in neurodegenerative disease. J. Mol. Neurosci. 45, 445\u2013452 (2011).","journal-title":"J. Mol. Neurosci."},{"key":"BFnrd2018109_CR153","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1093\/hmg\/ddt192","volume":"22","author":"ML Hebron","year":"2013","unstructured":"Hebron, M. L., Lonskaya, I. & Moussa, C. E. Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of \u03b1-synuclein in Parkinson's disease models. Hum. Mol. Genet. 22, 3315\u20133328 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrd2018109_CR154","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.1093\/hmg\/ddu211","volume":"23","author":"C Wenqiang","year":"2014","unstructured":"Wenqiang, C. et al. Parkin-mediated reduction of nuclear and soluble TDP-43 reverses behavioral decline in symptomatic mice. Hum. Mol. Genet. 23, 4960\u20134969 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrd2018109_CR155","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3233\/JPD-160867","volume":"6","author":"F Pagan","year":"2016","unstructured":"Pagan, F. et al. Nilotinib effects in Parkinson's disease and dementia with Lewy bodies. J. Parkinsons Dis. 6, 503\u2013517 (2016).","journal-title":"J. Parkinsons Dis."},{"key":"BFnrd2018109_CR156","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nrn.2017.42","volume":"18","author":"A Satoh","year":"2017","unstructured":"Satoh, A., Imai, S. I. & Guarente, L. The brain, sirtuins, and ageing. Nat. Rev. Neurosci. 18, 362\u2013374 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnrd2018109_CR157","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1474-9726.2009.00487.x","volume":"8","author":"HT Kang","year":"2009","unstructured":"Kang, H. T. & Hwang, E. S. Nicotinamide enhances mitochondria quality through autophagy activation in human cells. Aging Cell 8, 426\u2013438 (2009).","journal-title":"Aging Cell"},{"key":"BFnrd2018109_CR158","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3109\/10715762.2014.907889","volume":"48","author":"MF Wu","year":"2014","unstructured":"Wu, M. F., Yin, J. H., Hwang, C. S., Tang, C. M. & Yang, D. I. NAD attenuates oxidative DNA damages induced by amyloid \u03b2-peptide in primary rat cortical neurons. Free Radic. Res. 48, 794\u2013805 (2014).","journal-title":"Free Radic. Res."},{"key":"BFnrd2018109_CR159","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.neurobiolaging.2012.11.020","volume":"34","author":"D Liu","year":"2013","unstructured":"Liu, D. et al. Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession. Neurobiol. Aging 34, 1564\u20131580 (2013).","journal-title":"Neurobiol. Aging"},{"key":"BFnrd2018109_CR160","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1007\/s11064-016-1950-9","volume":"41","author":"H Deng","year":"2016","unstructured":"Deng, H. & Mi, M. T. Resveratrol attenuates A\u03b225-35 caused neurotoxicity by inducing autophagy through the TyrRS-PARP1-SIRT1 signaling pathway. Neurochem. Res. 41, 2367\u20132379 (2016).","journal-title":"Neurochem. Res."},{"key":"BFnrd2018109_CR161","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JAD-151040","volume":"54","author":"S Martire","year":"2016","unstructured":"Martire, S. et al. Bioenergetic impairment in animal and cellular models of Alzheimer's disease: PARP-1 inhibition rescues metabolic dysfunctions. J. Alzheimers Dis. 54, 307\u2013324 (2016).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrd2018109_CR162","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2011.04.068","volume":"408","author":"SH Park","year":"2011","unstructured":"Park, S. H. et al. Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid \u03b2-induced cognitive deficits associated with decreased amyloid \u03b2 accumulation. Biochem. Biophys. Res. Commun. 408, 602\u2013608 (2011).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrd2018109_CR163","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/jnr.23310","volume":"92","author":"HR Lee","year":"2014","unstructured":"Lee, H. R. et al. Attenuation of \u03b2-amyloid-induced tauopathy via activation of CK2\u03b1\/SIRT1: targeting for cilostazol. J. Neurosci. Res. 92, 206\u2013217 (2014).","journal-title":"J. Neurosci. Res."},{"key":"BFnrd2018109_CR164","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd4391","volume":"13","author":"F Madeo","year":"2014","unstructured":"Madeo, F., Pietrocola, F., Eisenberg, T. & Kroemer, G. Caloric restriction mimetics: towards a molecular definition. Nat. Rev. Drug Discov. 13, 727\u2013740 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnrd2018109_CR165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2017.03.004","volume":"156","author":"MJ Millan","year":"2017","unstructured":"Millan, M. J. Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer's disease: an integrative review. Prog. Neurobiol. 156, 1\u201368 (2017).","journal-title":"Prog. Neurobiol."},{"key":"BFnrd2018109_CR166","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1074\/jbc.M115.675488","volume":"291","author":"G Park","year":"2016","unstructured":"Park, G. et al. Regulation of histone acetylation by autophagy in Parkinson disease. J. Biol. Chem. 291, 3531\u20133540 (2016).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2018109_CR167","doi-asserted-by":"crossref","first-page":"eaan2788","DOI":"10.1126\/science.aan2788","volume":"359","author":"F Madeo","year":"2018","unstructured":"Madeo, F., Eisenberg, T., Pietrocola, F. & Kroemer, G. Spermidine in health and disease. Science 359, eaan2788 (2018).","journal-title":"Science"},{"key":"BFnrd2018109_CR168","doi-asserted-by":"crossref","first-page":"e2738","DOI":"10.1038\/cddis.2017.161","volume":"8","author":"Y Yang","year":"2017","unstructured":"Yang, Y. et al. Induction of autophagy by spermidine is neuroprotective via inhibition of caspase 3-mediated Beclin 1 cleavage. Cell Death Dis. 8, e2738 (2017).","journal-title":"Cell Death Dis."},{"key":"BFnrd2018109_CR169","doi-asserted-by":"crossref","first-page":"15024","DOI":"10.1073\/pnas.1206362109","volume":"109","author":"IF Wang","year":"2012","unstructured":"Wang, I. F. et al. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc. Natl Acad. Sci. USA 109, 15024\u201315029 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2018109_CR170","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.4161\/15384101.2014.973309","volume":"13","author":"S Buttner","year":"2014","unstructured":"Buttner, S. et al. Spermidine protects against \u03b1-synuclein neurotoxicity. Cell Cycle 13, 3903\u20133908 (2014).","journal-title":"Cell Cycle"},{"key":"BFnrd2018109_CR171","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.molcel.2014.01.016","volume":"53","author":"G Marino","year":"2014","unstructured":"Marino, G. et al. Regulation of autophagy by cytosolic acetyl-coenzyme A. Mol. Cell 53, 710\u2013725 (2014).","journal-title":"Mol. Cell"},{"key":"BFnrd2018109_CR172","doi-asserted-by":"crossref","first-page":"e0120352","DOI":"10.1371\/journal.pone.0120352","volume":"10","author":"S Aubry","year":"2015","unstructured":"Aubry, S. et al. Assembly and interrogation of Alzheimer's disease genetic networks reveal novel regulators of progression. PLoS One 10, e0120352 (2015).","journal-title":"PLoS One"},{"key":"BFnrd2018109_CR173","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1084\/jem.20121239","volume":"209","author":"J Yao","year":"2012","unstructured":"Yao, J. et al. Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease. J. Exp. Med. 209, 2501\u20132513 (2012).","journal-title":"J. Exp. Med."},{"key":"BFnrd2018109_CR174","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature11866","volume":"494","author":"S Shoji-Kawata","year":"2013","unstructured":"Shoji-Kawata, S. et al. Identification of a candidate therapeutic autophagy-inducing peptide. Nature 494, 201\u2013206 (2013).","journal-title":"Nature"},{"key":"BFnrd2018109_CR175","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4161\/auto.8.1.18313","volume":"8","author":"JH Lu","year":"2012","unstructured":"Lu, J. H. et al. Isorhynchophylline, a natural alkaloid, promotes the degradation of \u03b1-synuclein in neuronal cells via inducing autophagy. Autophagy 8, 98\u2013108 (2012).","journal-title":"Autophagy"},{"key":"BFnrd2018109_CR176","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/bs.ircmb.2016.09.002","volume":"330","author":"A Di Rita","year":"2017","unstructured":"Di Rita, A. & Strappazzon, F. AMBRA1, a novel BH3-like protein: new insights into the AMBRA1-BCL2-family proteins relationship. Int. Rev. Cell. Mol. Biol. 330, 85\u2013113 (2017).","journal-title":"Int. Rev. Cell. Mol. Biol."},{"key":"BFnrd2018109_CR177","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1080\/15548627.2015.1017191","volume":"11","author":"JM Pedro","year":"2015","unstructured":"Pedro, J. M. et al. BAX and BAK1 are dispensable for ABT-737-induced dissociation of the BCL2-BECN1 complex and autophagy. Autophagy 11, 452\u2013459 (2015).","journal-title":"Autophagy"},{"key":"BFnrd2018109_CR178","doi-asserted-by":"crossref","first-page":"e1006962","DOI":"10.1371\/journal.pgen.1006962","volume":"13","author":"A Rocchi","year":"2017","unstructured":"Rocchi, A. et al. A Becn1 mutation mediates hyperactive autophagic sequestration of amyloid oligomers and improved cognition in Alzheimer's disease. PLoS Genet. 13, e1006962 (2017).","journal-title":"PLoS Genet."},{"key":"BFnrd2018109_CR179","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pneurobio.2013.06.002","volume":"106\u2013107","author":"A Salminen","year":"2013","unstructured":"Salminen, A. et al. Impaired autophagy and APP processing in Alzheimer's disease: the potential role of Beclin 1 interactome. Prog. Neurobiol. 106\u2013107, 33\u201354 (2013).","journal-title":"Prog. Neurobiol."},{"key":"BFnrd2018109_CR180","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neuint.2017.05.013","volume":"117","author":"C Vidoni","year":"2017","unstructured":"Vidoni, C., Secomandi, E., Castiglioni, A., Melone, M. A. B. & Isidoro, C. Resveratrol protects neuronal-like cells expressing mutant Huntingtin from dopamine toxicity by rescuing ATG4-mediated autophagosome formation. Neurochem. Int. 117, 174\u2013187 (2017).","journal-title":"Neurochem. Int."},{"key":"BFnrd2018109_CR181","doi-asserted-by":"crossref","first-page":"42014","DOI":"10.1038\/srep42014","volume":"7","author":"T Kovacs","year":"2017","unstructured":"Kovacs, T. et al. The small molecule AUTEN-99 (autophagy enhancer-99) prevents the progression of neurodegenerative symptoms. Sci. Rep. 7, 42014 (2017).","journal-title":"Sci. Rep."},{"key":"BFnrd2018109_CR182","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1385\/JMN:28:2:111","volume":"28","author":"KI Seyb","year":"2006","unstructured":"Seyb, K. I., Ansar, S., Bean, J. & Michaelis, M. L. \u03b2-Amyloid and endoplasmic reticulum stress responses in primary neurons: effects of drugs that interact with the cytoskeleton. J. Mol. Neurosci. 28, 111\u2013123 (2006).","journal-title":"J. Mol. Neurosci."},{"key":"BFnrd2018109_CR183","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1523\/JNEUROSCI.4922-11.2012","volume":"32","author":"B Zhang","year":"2012","unstructured":"Zhang, B. et al. The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice. J. Neurosci. 32, 3601\u20133611 (2012).","journal-title":"J. Neurosci."},{"key":"BFnrd2018109_CR184","doi-asserted-by":"crossref","first-page":"R318","DOI":"10.1016\/j.cub.2017.02.061","volume":"27","author":"DJ Kast","year":"2017","unstructured":"Kast, D. J. & Dominguez, R. The Cytoskeleton-autophagy connection. Curr. Biol. 27, R318\u2013R326 (2017).","journal-title":"Curr. Biol."},{"key":"BFnrd2018109_CR185","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1007\/s00018-016-2224-z","volume":"73","author":"AS Coutts","year":"2016","unstructured":"Coutts, A. S. & La Thangue, N. B. Regulation of actin nucleation and autophagosome formation. Cell. Mol. Life Sci. 73, 3249\u20133263 (2016).","journal-title":"Cell. Mol. Life Sci."},{"key":"BFnrd2018109_CR186","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.molcel.2016.08.021","volume":"63","author":"Z Wang","year":"2016","unstructured":"Wang, Z. et al. The Vici syndrome protein EPG5 Is a Rab7 effector that determines the fusion specificity of autophagosomes with late endosomes\/lysosomes. Mol. Cell 63, 781\u2013795 (2016).","journal-title":"Mol. Cell"},{"key":"BFnrd2018109_CR187","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.4490","volume":"24","author":"Y Shi","year":"2018","unstructured":"Shi, Y. et al. Haploinsufficiency leads to neuro-degeneration in C9ORF72 ALS\/FTD human induced motor neurons. Nat. Med. 24, 313\u2013325 (2018).","journal-title":"Nat. Med."},{"key":"BFnrd2018109_CR188","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nchembio.1508","volume":"10","author":"VJ Mecozzi","year":"2014","unstructured":"Mecozzi, V. J. et al. Pharmacological chaperones stabilize retromer to limit APP processing. Nat. Chem. Biol. 10, 443\u2013449 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"BFnrd2018109_CR189","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neuroscience.2014.01.001","volume":"263","author":"EE Coffey","year":"2014","unstructured":"Coffey, E. E., Beckel, J. M., Laties, A. M. & Mitchell, C. H. Lysosomal alkalization and dysfunction in human fibroblasts with the Alzheimer's disease-linked presenilin 1 A246E mutation can be reversed with cAMP. Neuroscience 263, 111\u2013124 (2014).","journal-title":"Neuroscience"},{"key":"BFnrd2018109_CR190","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.18632\/aging.101144","volume":"8","author":"JF Moruno-Manchon","year":"2016","unstructured":"Moruno-Manchon, J. F. et al. TFEB ameliorates the impairment of the autophagy-lysosome pathway in neurons induced by doxorubicin. Aging 8, 3507\u20133519 (2016).","journal-title":"Aging"},{"key":"BFnrd2018109_CR191","doi-asserted-by":"crossref","first-page":"E1373","DOI":"10.1073\/pnas.1419669112","volume":"112","author":"W Wang","year":"2015","unstructured":"Wang, W. et al. Up-regulation of lysosomal TRPML1 channels is essential for lysosomal adaptation to nutrient starvation. Proc. Natl Acad. Sci. USA 112, E1373\u20131381 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2018109_CR192","doi-asserted-by":"crossref","first-page":"11485","DOI":"10.1523\/JNEUROSCI.0210-14.2014","volume":"34","author":"M Bae","year":"2014","unstructured":"Bae, M. et al. Activation of TRPML1 clears intraneuronal A\u03b2 in preclinical models of HIV infection. J. Neurosci. 34, 11485\u201311503 (2014).","journal-title":"J. Neurosci."},{"key":"BFnrd2018109_CR193","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrn.2017.36","volume":"18","author":"AW Kao","year":"2017","unstructured":"Kao, A. W., McKay, A., Singh, P. P., Brunet, A. & Huang, E. J. Progranulin, lysosomal regulation and neurodegenerative disease. Nat. Rev. Neurosci. 18, 325\u2013333 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnrd2018109_CR194","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1523\/JNEUROSCI.3081-17.2018","volume":"38","author":"AE Arrant","year":"2018","unstructured":"Arrant, A. E., Onyilo, V. C., Unger, D. E. & Roberson, E. D. Progranulin gene therapy improves lysosomal dysfunction and microglial pathology associated with frontotemporal dementia and neuronal ceroid lipofuscinosis. J. Neurosci. 38, 2341\u20132358 (2018).","journal-title":"J. Neurosci."},{"key":"BFnrd2018109_CR195","doi-asserted-by":"crossref","first-page":"e0120819","DOI":"10.1371\/journal.pone.0120819","volume":"10","author":"K Kilpatrick","year":"2015","unstructured":"Kilpatrick, K., Zeng, Y., Hancock, T. & Segatori, L. Genetic and chemical activation of TFEB mediates clearance of aggregated \u03b1-synuclein. PLoS One 10, e0120819 (2015).","journal-title":"PLoS One"},{"key":"BFnrd2018109_CR196","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1016\/j.neurobiolaging.2015.09.006","volume":"36","author":"BR Seo","year":"2015","unstructured":"Seo, B. R., Lee, S. J., Cho, K. S., Yoon, Y. H. & Koh, J. Y. The zinc ionophore clioquinol reverses autophagy arrest in chloroquine-treated ARPE-19 cells and in APP\/mutant presenilin-1-transfected Chinese hamster ovary cells. Neurobiol. Aging 36, 3228\u20133238 (2015).","journal-title":"Neurobiol. Aging"},{"key":"BFnrd2018109_CR197","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0896-6273(01)00317-8","volume":"30","author":"RA Cherny","year":"2001","unstructured":"Cherny, R. A. et al. Treatment with a copper-zinc chelator markedly and rapidly inhibits \u03b2-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30, 665\u2013676 (2001).","journal-title":"Neuron"},{"key":"BFnrd2018109_CR198","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neuron.2008.10.001","volume":"60","author":"B Sun","year":"2008","unstructured":"Sun, B. et al. Cystatin C-cathepsin B axis regulates amyloid \u03b2 levels and associated neuronal deficits in an animal model of Alzheimer's disease. Neuron 60, 247\u2013257 (2008).","journal-title":"Neuron"},{"key":"BFnrd2018109_CR199","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1073\/pnas.1616152114","volume":"114","author":"SP Sardi","year":"2017","unstructured":"Sardi, S. P. et al. Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models. Proc. Natl Acad. Sci. USA 114, 2699\u20132704 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2018109_CR200","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.stemcr.2017.01.011","volume":"8","author":"SY Yang","year":"2017","unstructured":"Yang, S. Y., Beavan, M., Chau, K. Y., Taanman, J. W. & Schapira, A. H. A. Human neural crest stem cell-derived dopaminergic neuronal model recapitulates biochemical abnormalities in GBA1 mutation carriers. Stem Cell Rep. 8, 728\u2013742 (2017).","journal-title":"Stem Cell Rep."},{"key":"BFnrd2018109_CR201","doi-asserted-by":"crossref","first-page":"31380","DOI":"10.1038\/srep31380","volume":"6","author":"A Sanchez-Martinez","year":"2016","unstructured":"Sanchez-Martinez, A. et al. Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models. Sci. Rep. 6, 31380 (2016).","journal-title":"Sci. Rep."},{"key":"BFnrd2018109_CR202","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/ana.24790","volume":"80","author":"A Migdalska-Richards","year":"2016","unstructured":"Migdalska-Richards, A., Daly, L., Bezard, E. & Schapira, A. H. Ambroxol effects in glucocerebrosidase and \u03b1-synuclein transgenic mice. Ann. Neurol. 80, 766\u2013775 (2016).","journal-title":"Ann. Neurol."},{"key":"BFnrd2018109_CR203","doi-asserted-by":"crossref","first-page":"7441","DOI":"10.1523\/JNEUROSCI.0636-16.2016","volume":"36","author":"E Aflaki","year":"2016","unstructured":"Aflaki, E. et al. A new glucocerebrosidase chaperone reduces \u03b1-synuclein and glycolipid levels in iPSC-derived dopaminergic neurons from patients with Gaucher disease and parkinsonism. J. Neurosci. 36, 7441\u20137452 (2016).","journal-title":"J. Neurosci."},{"key":"BFnrd2018109_CR204","doi-asserted-by":"crossref","first-page":"10211","DOI":"10.1074\/jbc.M113.506246","volume":"289","author":"W Song","year":"2014","unstructured":"Song, W., Wang, F., Lotfi, P., Sardiello, M. & Segatori, L. 2-Hydroxypropyl-\u03b2-cyclodextrin promotes transcription factor EB-mediated activation of autophagy: implications for therapy. J. Biol. Chem. 289, 10211\u201310222 (2014).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2018109_CR205","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.freeradbiomed.2016.03.022","volume":"95","author":"WJ Duan","year":"2016","unstructured":"Duan, W. J. et al. A SIRT3\/AMPK\/autophagy network orchestrates the protective effects of trans-resveratrol in stressed peritoneal macrophages and RAW 264.7 macrophages. Free Radic. Biol. Med. 95, 230\u2013242 (2016).","journal-title":"Free Radic. Biol. Med."},{"key":"BFnrd2018109_CR206","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1474-4422(17)30115-1","volume":"16","author":"G Writing","year":"2017","unstructured":"Writing, G. & Edaravone, A. L. S. S. G. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet. Neurol. 16, 505\u2013512 (2017).","journal-title":"Lancet. Neurol."},{"key":"BFnrd2018109_CR207","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.tips.2015.08.014","volume":"36","author":"S Li","year":"2015","unstructured":"Li, S. & Laher, I. Exercise pills: at the starting line. Trends Pharmacol. Sci. 36, 906\u2013917 (2015).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnrd2018109_CR208","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fnins.2017.00254","volume":"11","author":"RE Lackie","year":"2017","unstructured":"Lackie, R. E. et al. The Hsp70\/Hsp90 chaperone machinery in neurodegenerative diseases. Front. Neurosci. 11, 254 (2017).","journal-title":"Front. Neurosci."},{"key":"BFnrd2018109_CR209","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nrd3453","volume":"10","author":"DW Neef","year":"2011","unstructured":"Neef, D. W., Jaeger, A. M. & Thiele, D. J. Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases. Nat. Rev. Drug Discov. 10, 930\u2013944 (2011).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnrd2018109_CR210","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pharmthera.2013.08.003","volume":"141","author":"B Kalmar","year":"2014","unstructured":"Kalmar, B., Lu, C. H. & Greensmith, L. The role of heat shock proteins in Amyotrophic Lateral Sclerosis: the therapeutic potential of Arimoclomol. Pharmacol. Ther. 141, 40\u201354 (2014).","journal-title":"Pharmacol. Ther."},{"key":"BFnrd2018109_CR211","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2478\/s11658-009-0002-8","volume":"14","author":"B Kalmar","year":"2009","unstructured":"Kalmar, B. & Greensmith, L. Activation of the heat shock response in a primary cellular model of motoneuron neurodegeneration-evidence for neuroprotective and neurotoxic effects. Cell. Mol. Biol. Lett. 14, 319\u2013335 (2009).","journal-title":"Cell. Mol. Biol. Lett."},{"key":"BFnrd2018109_CR212","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nm1021","volume":"10","author":"D Kieran","year":"2004","unstructured":"Kieran, D. et al. Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice. Nat. Med. 10, 402\u2013405 (2004).","journal-title":"Nat. Med."},{"key":"BFnrd2018109_CR213","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nchembio.1140","volume":"9","author":"AM Wang","year":"2013","unstructured":"Wang, A. M. et al. Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation. Nat. Chem. Biol. 9, 112\u2013118 (2013).","journal-title":"Nat. Chem. Biol."},{"key":"BFnrd2018109_CR214","doi-asserted-by":"crossref","first-page":"10757","DOI":"10.1038\/srep10757","volume":"5","author":"JH Lee","year":"2015","unstructured":"Lee, J. H. et al. Facilitated Tau degradation by USP14 aptamers via enhanced proteasome activity. Sci. Rep. 5, 10757 (2015).","journal-title":"Sci. Rep."},{"key":"BFnrd2018109_CR215","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.bbadis.2017.03.017","volume":"1863","author":"MJ Kiprowska","year":"2017","unstructured":"Kiprowska, M. J. et al. Neurotoxic mechanisms by which the USP14 inhibitor IU1 depletes ubiquitinated proteins and Tau in rat cerebral cortical neurons: relevance to Alzheimer's disease. Biochim. Biophys. Acta 1863, 1157\u20131170 (2017).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrd2018109_CR216","doi-asserted-by":"crossref","first-page":"19209","DOI":"10.1074\/jbc.M117.815126","volume":"292","author":"M Boselli","year":"2017","unstructured":"Boselli, M. et al. An inhibitor of the proteasomal deubiquitinating enzyme USP14 induces tau elimination in cultured neurons. J. Biol. Chem. 292, 19209\u201319221 (2017).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2018109_CR217","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrd.2017.152","volume":"17","author":"JA Harrigan","year":"2018","unstructured":"Harrigan, J. A., Jacq, X., Martin, N. M. & Jackson, S. P. Deubiquitylating enzymes and drug discovery: emerging opportunities. Nat. Rev. Drug Discov. 17, 57\u201378 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnrd2018109_CR218","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/mp.2016.104","volume":"22","author":"B Wang","year":"2017","unstructured":"Wang, B. et al. A CNS-permeable Hsp90 inhibitor rescues synaptic dysfunction and memory loss in APP-overexpressing Alzheimer's mouse model via an HSF1-mediated mechanism. Mol. Psychiatry 22, 990\u20131001 (2017).","journal-title":"Mol. Psychiatry"},{"key":"BFnrd2018109_CR219","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/hmg\/ddh083","volume":"13","author":"L Petrucelli","year":"2004","unstructured":"Petrucelli, L. et al. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum. Mol. Genet. 13, 703\u2013714 (2004).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrd2018109_CR220","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1096\/fj.10-164624","volume":"25","author":"KM Danzer","year":"2011","unstructured":"Danzer, K. M. et al. Heat-shock protein 70 modulates toxic extracellular \u03b1-synuclein oligomers and rescues trans-synaptic toxicity. FASEB J. 25, 326\u2013336 (2011).","journal-title":"FASEB J."},{"key":"BFnrd2018109_CR221","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/nm1102-1185","volume":"8","author":"PK Auluck","year":"2002","unstructured":"Auluck, P. K. & Bonini, N. M. Pharmacological prevention of Parkinson disease in Drosophila. Nat. Med. 8, 1185\u20131186 (2002).","journal-title":"Nat. Med."},{"key":"BFnrd2018109_CR222","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1073\/pnas.0500055102","volume":"102","author":"N Agrawal","year":"2005","unstructured":"Agrawal, N. et al. Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila. Proc. Natl Acad. Sci. USA 102, 3777\u20133781 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2018109_CR223","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1523\/JNEUROSCI.0151-13.2014","volume":"34","author":"Y Chen","year":"2014","unstructured":"Chen, Y. et al. Hsp90 chaperone inhibitor 17-AAG attenuates A\u03b2-induced synaptic toxicity and memory impairment. J. Neurosci. 34, 2464\u20132470 (2014).","journal-title":"J. Neurosci."},{"key":"BFnrd2018109_CR224","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/2047-9158-2-24","volume":"2","author":"SW Ho","year":"2013","unstructured":"Ho, S. W. et al. Effects of 17-allylamino-17-demethoxygeldanamycin (17-AAG) in transgenic mouse models of frontotemporal lobar degeneration and Alzheimer's disease. Transl Neurodegener. 2, 24 (2013).","journal-title":"Transl Neurodegener."},{"key":"BFnrd2018109_CR225","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1172\/JCI57413","volume":"121","author":"J Labbadia","year":"2011","unstructured":"Labbadia, J. et al. Altered chromatin architecture underlies progressive impairment of the heat shock response in mouse models of Huntington disease. J. Clin. Invest. 121, 3306\u20133319 (2011).","journal-title":"J. Clin. Invest."},{"key":"BFnrd2018109_CR226","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s13238-017-0382-x","volume":"8","author":"X Guo","year":"2017","unstructured":"Guo, X., Huang, X. & Chen, M. J. Reversible phosphorylation of the 26S proteasome. Protein Cell 8, 255\u2013272 (2017).","journal-title":"Protein Cell"},{"key":"BFnrd2018109_CR227","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1042\/BCJ20160809","volume":"474","author":"JJS VerPlank","year":"2017","unstructured":"VerPlank, J. J. S. & Goldberg, A. L. Regulating protein breakdown through proteasome phosphorylation. Biochem. J. 474, 3355\u20133371 (2017).","journal-title":"Biochem. J."},{"key":"BFnrd2018109_CR228","first-page":"591","volume":"4","author":"C Bate","year":"2015","unstructured":"Bate, C. & Williams, A. cAMP-Inhibits cytoplasmic phospholipase A2 and protects neurons against amyloid-\u03b2-induced synapse damage. Biol. (Basel) 4, 591\u2013606 (2015).","journal-title":"Biol. (Basel)"},{"key":"BFnrd2018109_CR229","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm.4011","volume":"22","author":"N Myeku","year":"2016","unstructured":"Myeku, N. et al. Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling. Nat. Med. 22, 46\u201353 (2016).","journal-title":"Nat. Med."},{"key":"BFnrd2018109_CR230","doi-asserted-by":"crossref","first-page":"E7176","DOI":"10.1073\/pnas.1522332112","volume":"112","author":"S Lokireddy","year":"2015","unstructured":"Lokireddy, S., Kukushkin, N. V. & Goldberg, A. L. cAMP-induced phosphorylation of 26S proteasomes on Rpn6\/PSMD11 enhances their activity and the degradation of misfolded proteins. Proc. Natl Acad. Sci. USA 112, E7176\u2013E7185 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2018109_CR231","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1128\/MCB.01434-12","volume":"33","author":"JT Lin","year":"2013","unstructured":"Lin, J. T. et al. Regulation of feedback between protein kinase A and the proteasome system worsens Huntington's disease. Mol. Cell. Biol. 33, 1073\u20131084 (2013).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrd2018109_CR232","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1523\/JNEUROSCI.4427-11.2012","volume":"32","author":"SN Djakovic","year":"2012","unstructured":"Djakovic, S. N. et al. Phosphorylation of Rpt6 regulates synaptic strength in hippocampal neurons. J. Neurosci. 32, 5126\u20135131 (2012).","journal-title":"J. Neurosci."},{"key":"BFnrd2018109_CR233","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.chembiol.2017.05.010","volume":"24","author":"Y Leestemaker","year":"2017","unstructured":"Leestemaker, Y. et al. Proteasome activation by small molecules. Cell Chem. Biol. 24, 725\u2013736.e7 (2017).","journal-title":"Cell Chem. Biol."},{"key":"BFnrd2018109_CR234","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1021\/acs.jmedchem.7b00635","volume":"61","author":"AP Crew","year":"2017","unstructured":"Crew, A. P. et al. Identification and characterization of von hippel-lindau-recruiting proteolysis targeting chimeras (PROTACs) of TANK-binding kinase 1. J. Med. Chem. 61, 583\u2013598 (2017).","journal-title":"J. Med. Chem."},{"key":"BFnrd2018109_CR235","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1042\/BCJ20160762","volume":"474","author":"I Collins","year":"2017","unstructured":"Collins, I., Wang, H., Caldwell, J. J. & Chopra, R. Chemical approaches to targeted protein degradation through modulation of the ubiquitin-proteasome pathway. Biochem. J. 474, 1127\u20131147 (2017).","journal-title":"Biochem. J."},{"key":"BFnrd2018109_CR236","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.chembiol.2016.02.016","volume":"23","author":"TT Chu","year":"2016","unstructured":"Chu, T. T. et al. Specific knockdown of endogenous tau protein by peptide-directed ubiquitin-proteasome degradation. Cell Chem. Biol. 23, 453\u2013461 (2016).","journal-title":"Cell Chem. Biol."},{"key":"BFnrd2018109_CR237","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.cell.2017.10.033","volume":"171","author":"D Clift","year":"2017","unstructured":"Clift, D. et al. A Method for the acute and rapid degradation of endogenous proteins. Cell 171, 1692\u20131706 (2017).","journal-title":"Cell"},{"key":"BFnrd2018109_CR238","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bbrc.2016.10.065","volume":"480","author":"JS Choi","year":"2016","unstructured":"Choi, J. S. et al. cIAPs promote the proteasomal degradation of mutant SOD1 linked to familial amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 480, 422\u2013428 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrd2018109_CR239","doi-asserted-by":"crossref","first-page":"R834","DOI":"10.1016\/j.cub.2016.08.008","volume":"26","author":"JR Vangala","year":"2016","unstructured":"Vangala, J. R., Sotzny, F., Kruger, E., Deshaies, R. J. & Radhakrishnan, S. K. Nrf1 can be processed and activated in a proteasome-independent manner. Curr. Biol. 26, R834\u2013R835 (2016).","journal-title":"Curr. Biol."},{"key":"BFnrd2018109_CR240","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.redox.2017.01.006","volume":"11","author":"M Pajares","year":"2017","unstructured":"Pajares, M., Cuadrado, A. & Rojo, A. I. Modulation of proteostasis by transcription factor NRF2 and impact in neurodegenerative diseases. Redox Biol. 11, 543\u2013553 (2017).","journal-title":"Redox Biol."},{"key":"BFnrd2018109_CR241","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/acel.12111","volume":"12","author":"EN Tsakiri","year":"2013","unstructured":"Tsakiri, E. N. et al. Proteasome dysfunction in Drosophila signals to an Nrf2-dependent regulatory circuit aiming to restore proteostasis and prevent premature aging. Aging Cell 12, 802\u2013813 (2013).","journal-title":"Aging Cell"},{"key":"BFnrd2018109_CR242","first-page":"337","volume":"34","author":"A Opattova","year":"2015","unstructured":"Opattova, A., Cente, M., Novak, M. & Filipcik, P. The ubiquitin proteasome system as a potential therapeutic target for treatment of neurodegenerative diseases. Gen. Physiol. Biophys. 34, 337\u2013352 (2015).","journal-title":"Gen. Physiol. Biophys."},{"key":"BFnrd2018109_CR243","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nature18943","volume":"536","author":"A Rousseau","year":"2016","unstructured":"Rousseau, A. & Bertolotti, A. An evolutionarily conserved pathway controls proteasome homeostasis. Nature 536, 184\u2013189 (2016).","journal-title":"Nature"},{"key":"BFnrd2018109_CR244","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.molcel.2015.05.030","volume":"59","author":"E Arias","year":"2015","unstructured":"Arias, E. et al. Lysosomal mTORC2\/PHLPP1\/Akt regulate chaperone-mediated autophagy. Mol. Cell 59, 270\u2013284 (2015).","journal-title":"Mol. Cell"},{"key":"BFnrd2018109_CR245","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/nchembio.1230","volume":"9","author":"J Anguiano","year":"2013","unstructured":"Anguiano, J. et al. Chemical modulation of chaperone-mediated autophagy by retinoic acid derivatives. Nat. Chem. Biol. 9, 374\u2013382 (2013).","journal-title":"Nat. Chem. Biol."},{"key":"BFnrd2018109_CR246","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awx005","volume":"140","author":"A Lopez","year":"2017","unstructured":"Lopez, A. et al. A152T tau allele causes neurodegeneration that can be ameliorated in a zebrafish model by autophagy induction. Brain 140, 1128\u20131146 (2017).","journal-title":"Brain"},{"key":"BFnrd2018109_CR247","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1128\/MCB.00285-15","volume":"35","author":"YS Hou","year":"2015","unstructured":"Hou, Y. S. et al. Sestrin2 protects dopaminergic cells against rotenone toxicity through ampk-dependent autophagy activation. Mol. Cell. Biol. 35, 2740\u20132751 (2015).","journal-title":"Mol. Cell. Biol."},{"key":"BFnrd2018109_CR248","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.expneurol.2013.12.009","volume":"253","author":"YS Chen","year":"2014","unstructured":"Chen, Y. S., Chen, S. D., Wu, C. L., Huang, S. S. & Yang, D. I. Induction of sestrin2 as an endogenous protective mechanism against amyloid \u03b2-peptide neurotoxicity in primary cortical culture. Exp. Neurol. 253, 63\u201371 (2014).","journal-title":"Exp. Neurol."},{"key":"BFnrd2018109_CR249","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fnagi.2017.00083","volume":"9","author":"SS Shafiei","year":"2017","unstructured":"Shafiei, S. S., Guerrero-Munoz, M. J. & Castillo-Carranza, D. L. Tau oligomers: cytotoxicity, propagation, and mitochondrial damage. Front. Aging Neurosci. 9, 83 (2017).","journal-title":"Front. Aging Neurosci."},{"key":"BFnrd2018109_CR250","doi-asserted-by":"crossref","first-page":"E469","DOI":"10.3390\/ijms18020469","volume":"18","author":"D Valdinocci","year":"2017","unstructured":"Valdinocci, D., Radford, R. A., Siow, S. M., Chung, R. S. & Pountney, D. L. Potential modes of intercellular \u03b1-synuclein transmission. Int. J. Mol. Sci. 18, E469 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"BFnrd2018109_CR251","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00018-017-2664-0","volume":"75","author":"K Laulagnier","year":"2017","unstructured":"Laulagnier, K. et al. Amyloid precursor protein products concentrate in a subset of exosomes specifically endocytosed by neurons. Cell. Mol. Life Sci. 75, 757\u2013773 (2017).","journal-title":"Cell. Mol. Life Sci."},{"key":"BFnrd2018109_CR252","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nn.4328","volume":"19","author":"JW Wu","year":"2016","unstructured":"Wu, J. W. et al. Neuronal activity enhances tau propagation and tau pathology in vivo. Nat. Neurosci. 19, 1085\u20131092 (2016).","journal-title":"Nat. Neurosci."},{"key":"BFnrd2018109_CR253","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3233\/JAD-150379","volume":"48","author":"NK Jha","year":"2015","unstructured":"Jha, N. K. et al. Impact of insulin degrading enzyme and neprilysin in Alzheimer's disease biology: characterization of putative cognates for therapeutic applications. J. Alzheimers Dis. 48, 891\u2013917 (2015).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrd2018109_CR254","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/1567205012666141218140953","volume":"12","author":"RJ Baranello","year":"2015","unstructured":"Baranello, R. J. et al. Amyloid-\u03b2 protein clearance and degradation (ABCD) pathways and their role in Alzheimer's disease. Curr. Alzheimer Res. 12, 32\u201346 (2015).","journal-title":"Curr. Alzheimer Res."},{"key":"BFnrd2018109_CR255","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature21695","volume":"543","author":"L Ruan","year":"2017","unstructured":"Ruan, L. et al. Cytosolic proteostasis through importing of misfolded proteins into mitochondria. Nature 543, 443\u2013446 (2017).","journal-title":"Nature"},{"key":"BFnrd2018109_CR256","doi-asserted-by":"crossref","first-page":"a006379","DOI":"10.1101\/cshperspect.a006379","volume":"2","author":"T Saido","year":"2012","unstructured":"Saido, T. & Leissring, M. A. Proteolytic degradation of amyloid \u03b2-protein. Cold Spring Harb. Perspect. Med. 2, a006379 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"BFnrd2018109_CR257","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuron.2010.06.021","volume":"67","author":"JP Miller","year":"2010","unstructured":"Miller, J. P. et al. Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease. Neuron 67, 199\u2013212 (2010).","journal-title":"Neuron"},{"key":"BFnrd2018109_CR258","doi-asserted-by":"crossref","first-page":"620581","DOI":"10.1155\/2015\/620581","volume":"2015","author":"M Brkic","year":"2015","unstructured":"Brkic, M., Balusu, S., Libert, C. & Vandenbroucke, R. E. Friends or foes: matrix metalloproteinases and their multifaceted roles in neurodegenerative diseases. Mediators Inflamm. 2015, 620581 (2015).","journal-title":"Mediators Inflamm."},{"key":"BFnrd2018109_CR259","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.tips.2017.10.008","volume":"39","author":"IV Kurochkin","year":"2017","unstructured":"Kurochkin, I. V., Guarnera, E. & Berezovsky, I. N. Insulin-degrading enzyme in the fight against Alzheimer's disease. Trends Pharmacol. Sci. 39, 49\u201358 (2017).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnrd2018109_CR260","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3233\/JAD-2010-101197","volume":"22","author":"W Maetzler","year":"2010","unstructured":"Maetzler, W. et al. Neprilysin activity in cerebrospinal fluid is associated with dementia and amyloid-\u03b242 levels in Lewy body disease. J. Alzheimers Dis. 22, 933\u2013938 (2010).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrd2018109_CR261","doi-asserted-by":"crossref","first-page":"8754","DOI":"10.1073\/pnas.0710823105","volume":"105","author":"JS Jacobsen","year":"2008","unstructured":"Jacobsen, J. S. et al. Enhanced clearance of A\u03b2 in brain by sustaining the plasmin proteolysis cascade. Proc. Natl Acad. Sci. USA 105, 8754\u20138759 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2018109_CR262","doi-asserted-by":"crossref","first-page":"24862","DOI":"10.1074\/jbc.M112.348128","volume":"287","author":"KS Kim","year":"2012","unstructured":"Kim, K. S. et al. Proteolytic cleavage of extracellular \u03b1-synuclein by plasmin: implications for Parkinson disease. J. Biol. Chem. 287, 24862\u201324872 (2012).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2018109_CR263","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fnagi.2014.00290","volume":"6","author":"S Saito","year":"2014","unstructured":"Saito, S. & Ihara, M. New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy. Front. Aging Neurosci. 6, 290 (2014).","journal-title":"Front. Aging Neurosci."},{"key":"BFnrd2018109_CR264","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/mt.2012.66","volume":"21","author":"B Spencer","year":"2013","unstructured":"Spencer, B. et al. Lentivirus mediated delivery of neurosin promotes clearance of wild-type \u03b1-synuclein and reduces the pathology in an \u03b1-synuclein model of LBD. Mol. Ther. 21, 31\u201341 (2013).","journal-title":"Mol. Ther."},{"key":"BFnrd2018109_CR265","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","volume":"11","author":"JM Tarasoff-Conway","year":"2015","unstructured":"Tarasoff-Conway, J. M. et al. Clearance systems in the brain-implications for Alzheimer disease. Nat. Rev. Neurol. 11, 457\u2013470 (2015).","journal-title":"Nat. Rev. Neurol."},{"key":"BFnrd2018109_CR266","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.24406","volume":"78","author":"J Drouin-Ouellet","year":"2015","unstructured":"Drouin-Ouellet, J. et al. Cerebrovascular and blood-brain barrier impairments in Huntington's disease: potential implications for its pathophysiology. Ann. Neurol. 78, 160\u2013177 (2015).","journal-title":"Ann. Neurol."},{"key":"BFnrd2018109_CR267","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fncel.2014.00211","volume":"8","author":"R Cabezas","year":"2014","unstructured":"Cabezas, R. et al. Astrocytic modulation of blood brain barrier: perspectives on Parkinson's disease. Front. Cell Neurosci. 8, 211 (2014).","journal-title":"Front. Cell Neurosci."},{"key":"BFnrd2018109_CR268","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jalz.2016.04.003","volume":"12","author":"M Shi","year":"2016","unstructured":"Shi, M. et al. CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease. Alzheimers Dement. 12, 1125\u20131131 (2016).","journal-title":"Alzheimers Dement."},{"key":"BFnrd2018109_CR269","first-page":"118","volume":"163\u2013164","author":"BL Sun","year":"2017","unstructured":"Sun, B. L. et al. Lymphatic drainage system of the brain: A novel target for intervention of neurological diseases. Prog Neurobiol. 163\u2013164, 118\u2013143 (2017).","journal-title":"Prog Neurobiol."},{"key":"BFnrd2018109_CR270","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic, B. V. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. Neurosci. 12, 723\u2013738 (2011).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFnrd2018109_CR271","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fnagi.2014.00093","volume":"6","author":"T Kanekiyo","year":"2014","unstructured":"Kanekiyo, T. & Bu, G. The low-density lipoprotein receptor-related protein 1 and amyloid-\u03b2 clearance in Alzheimer's disease. Front. Aging Neurosci. 6, 93 (2014).","journal-title":"Front. Aging Neurosci."},{"key":"BFnrd2018109_CR272","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10014-016-0255-7","volume":"33","author":"M Ueno","year":"2016","unstructured":"Ueno, M. et al. Blood-brain barrier and blood-cerebrospinal fluid barrier in normal and pathological conditions. Brain Tumor Pathol. 33, 89\u201396 (2016).","journal-title":"Brain Tumor Pathol."},{"key":"BFnrd2018109_CR273","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.2174\/138161211797440122","volume":"17","author":"AL Bartels","year":"2011","unstructured":"Bartels, A. L. Blood-brain barrier P-glycoprotein function in neurodegenerative disease. Curr. Pharm. Des. 17, 2771\u20132777 (2011).","journal-title":"Curr. Pharm. Des."},{"key":"BFnrd2018109_CR274","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1241224","volume":"342","author":"L Xie","year":"2013","unstructured":"Xie, L. et al. Sleep drives metabolite clearance from the adult brain. Science 342, 373\u2013377 (2013).","journal-title":"Science"},{"key":"BFnrd2018109_CR275","doi-asserted-by":"crossref","first-page":"16180","DOI":"10.1523\/JNEUROSCI.3020-14.2014","volume":"34","author":"JJ Iliff","year":"2014","unstructured":"Iliff, J. J. et al. Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury. J. Neurosci. 34, 16180\u201316193 (2014).","journal-title":"J. Neurosci."},{"key":"BFnrd2018109_CR276","first-page":"4948","volume":"23","author":"YL Lan","year":"2017","unstructured":"Lan, Y. L. et al. Aquaporin 4 in astrocytes is a target for therapy in Alzheimer's disease. Curr. Pharm. Des. 23, 4948\u20134957 (2017).","journal-title":"Curr. Pharm. Des."},{"key":"BFnrd2018109_CR277","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/bpa.12369","volume":"27","author":"A Hoshi","year":"2017","unstructured":"Hoshi, A. et al. Expression of aquaporin 1 and aquaporin 4 in the temporal neocortex of patients with Parkinson's disease. Brain Pathol. 27, 160\u2013168 (2017).","journal-title":"Brain Pathol."},{"key":"BFnrd2018109_CR278","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13024-015-0056-1","volume":"10","author":"Z Xu","year":"2015","unstructured":"Xu, Z. et al. Deletion of aquaporin-4 in APP\/PS1 mice exacerbates brain A\u03b2 accumulation and memory deficits. Mol. Neurodegener. 10, 58 (2015).","journal-title":"Mol. Neurodegener."},{"key":"BFnrd2018109_CR279","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1007\/s12035-016-9831-4","volume":"54","author":"H Jiang","year":"2017","unstructured":"Jiang, H. et al. RBD and neurodegenerative diseases. Mol. Neurobiol. 54, 2997\u20133006 (2017).","journal-title":"Mol. Neurobiol."},{"key":"BFnrd2018109_CR280","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuroscience.2017.08.030","volume":"362","author":"N Yamamoto","year":"2017","unstructured":"Yamamoto, N. et al. Epigallocatechin gallate induces extracellular degradation of amyloid \u03b2-protein by increasing neprilysin secretion from astrocytes through activation of ERK and PI3K pathways. Neuroscience 362, 70\u201378 (2017).","journal-title":"Neuroscience"},{"key":"BFnrd2018109_CR281","doi-asserted-by":"crossref","first-page":"e0182896","DOI":"10.1371\/journal.pone.0182896","volume":"12","author":"JM Van Kampen","year":"2017","unstructured":"Van Kampen, J. M. & Kay, D. G. Progranulin gene delivery reduces plaque burden and synaptic atrophy in a mouse model of Alzheimer's disease. PLoS One 12, e0182896 (2017).","journal-title":"PLoS One"},{"key":"BFnrd2018109_CR282","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.brainres.2014.11.042","volume":"1597","author":"S Bi Oh","year":"2015","unstructured":"Bi Oh, S., Suh, N., Kim, I. & Lee, J. Y. Impacts of aging and amyloid-\u03b2 deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease. Brain Res. 1597, 159\u2013167 (2015).","journal-title":"Brain Res."},{"key":"BFnrd2018109_CR283","first-page":"383796","volume":"2012","author":"NN Nalivaeva","year":"2012","unstructured":"Nalivaeva, N. N., Belyaev, N. D., Zhuravin, I. A. & Turner, A. J. The Alzheimer's amyloid-degrading peptidase, neprilysin: can we control it? Int. J. Alzheimers Dis. 2012, 383796 (2012).","journal-title":"Int. J. Alzheimers Dis."},{"key":"BFnrd2018109_CR284","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/jnc.14068","volume":"142","author":"SF Spampinato","year":"2017","unstructured":"Spampinato, S. F., Merlo, S., Sano, Y., Kanda, T. & Sortino, M. A. Astrocytes contribute to A\u03b2-induced blood-brain barrier damage through activation of endothelial MMP9. J. Neurochem. 142, 464\u2013477 (2017).","journal-title":"J. Neurochem."},{"key":"BFnrd2018109_CR285","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrd.2017.95","volume":"16","author":"K Kingwell","year":"2017","unstructured":"Kingwell, K. Zeroing in on neurodegenerative \u03b1-synuclein. Nat. Rev. Drug Discov. 16, 371\u2013373 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnrd2018109_CR286","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/glia.22988","volume":"64","author":"PD Wes","year":"2016","unstructured":"Wes, P. D., Sayed, F. A., Bard, F. & Gan, L. Targeting microglia for the treatment of Alzheimer's Disease. Glia 64, 1710\u20131732 (2016).","journal-title":"Glia"},{"key":"BFnrd2018109_CR287","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny, J. et al. The antibody aducanumab reduces A\u03b2 plaques in Alzheimer's disease. Nature 537, 50\u201356 (2016).","journal-title":"Nature"},{"key":"BFnrd2018109_CR288","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2217\/imt-2016-0019","volume":"8","author":"F Panza","year":"2016","unstructured":"Panza, F. et al. Tau-based therapeutics for Alzheimer's disease: active and passive immunotherapy. Immunotherapy 8, 1119\u20131134 (2016).","journal-title":"Immunotherapy"},{"key":"BFnrd2018109_CR289","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/mds.26878","volume":"32","author":"DB Schenk","year":"2017","unstructured":"Schenk, D. B. et al. First-in-human assessment of PRX002, an anti-\u03b1-synuclein monoclonal antibody, in healthy volunteers. Mov Disord. 32, 211\u2013218 (2017).","journal-title":"Mov Disord."},{"key":"BFnrd2018109_CR290","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12987-016-0038-x","volume":"13","author":"B Shackleton","year":"2016","unstructured":"Shackleton, B., Crawford, F. & Bachmeier, C. Inhibition of ADAM10 promotes the clearance of A\u03b2 across the BBB by reducing LRP1 ectodomain shedding. Fluids Barriers CNS 13, 14 (2016).","journal-title":"Fluids Barriers CNS"},{"key":"BFnrd2018109_CR291","doi-asserted-by":"crossref","first-page":"22091","DOI":"10.1074\/jbc.M110.102277","volume":"285","author":"M Shinohara","year":"2010","unstructured":"Shinohara, M. et al. Reduction of brain \u03b2-amyloid (A\u03b2) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and A\u03b2 clearance. J. Biol. Chem. 285, 22091\u201322102 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2018109_CR292","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/JAD-2012-120319","volume":"31","author":"H Qosa","year":"2012","unstructured":"Qosa, H., Abuznait, A. H., Hill, R. A. & Kaddoumi, A. Enhanced brain amyloid-\u03b2 clearance by rifampicin and caffeine as a possible protective mechanism against Alzheimer's disease. J. Alzheimers Dis. 31, 151\u2013165 (2012).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrd2018109_CR293","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/brain\/aww042","volume":"139","author":"T Umeda","year":"2016","unstructured":"Umeda, T. et al. Rifampicin is a candidate preventive medicine against amyloid-\u03b2 and tau oligomers. Brain 139, 1568\u20131586 (2016).","journal-title":"Brain"},{"key":"BFnrd2018109_CR294","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/jnc.13122","volume":"134","author":"W Wan","year":"2015","unstructured":"Wan, W. et al. A\u03b2(1\u201342) oligomer-induced leakage in an in vitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins. J. Neurochem. 134, 382\u2013393 (2015).","journal-title":"J. Neurochem."},{"key":"BFnrd2018109_CR295","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1172\/JCI58642","volume":"122","author":"R Deane","year":"2012","unstructured":"Deane, R. et al. A multimodal RAGE-specific inhibitor reduces amyloid \u03b2-mediated brain disorder in a mouse model of Alzheimer disease. J. Clin. Invest. 122, 1377\u20131392 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFnrd2018109_CR296","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2377-14-12","volume":"14","author":"AH Burstein","year":"2014","unstructured":"Burstein, A. H. et al. Effect of TTP488 in patients with mild to moderate Alzheimer's disease. BMC Neurol. 14, 12 (2014).","journal-title":"BMC Neurol."},{"key":"BFnrd2018109_CR297","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.neuroscience.2015.10.006","volume":"310","author":"HF Zhao","year":"2015","unstructured":"Zhao, H. F. et al. Resveratrol decreases the insoluble A\u03b21-42 level in hippocampus and protects the integrity of the blood-brain barrier in AD rats. Neuroscience 310, 641\u2013649 (2015).","journal-title":"Neuroscience"},{"key":"BFnrd2018109_CR298","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11481-015-9627-8","volume":"11","author":"AW Corona","year":"2016","unstructured":"Corona, A. W., Kodoma, N., Casali, B. T. & Landreth, G. E. ABCA1 is necessary for bexarotene-mediated clearance of soluble amyloid \u03b2 from the hippocampus of APP\/PS1 mice. J. Neuroimmune Pharmacol. 11, 61\u201372 (2016).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"BFnrd2018109_CR299","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jconrel.2017.07.004","volume":"261","author":"CH Fan","year":"2017","unstructured":"Fan, C. H., Lin, C. Y., Liu, H. L. & Yeh, C. K. Ultrasound targeted CNS gene delivery for Parkinson's disease treatment. J. Control Release 261, 246\u2013262 (2017).","journal-title":"J. Control Release"},{"key":"BFnrd2018109_CR300","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2012.08.012","volume":"163","author":"A Burgess","year":"2012","unstructured":"Burgess, A., Huang, Y., Querbes, W., Sah, D. W. & Hynynen, K. Focused ultrasound for targeted delivery of siRNA and efficient knockdown of Htt expression. J. Control Release 163, 125\u2013129 (2012).","journal-title":"J. Control Release"},{"key":"BFnrd2018109_CR301","doi-asserted-by":"crossref","first-page":"45657","DOI":"10.1038\/srep45657","volume":"7","author":"D McMahon","year":"2017","unstructured":"McMahon, D., Bendayan, R. & Hynynen, K. Acute effects of focused ultrasound-induced increases in blood-brain barrier permeability on rat microvascular transcriptome. Sci. Rep. 7, 45657 (2017).","journal-title":"Sci. Rep."},{"key":"BFnrd2018109_CR302","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/acn3.79","volume":"1","author":"T Maki","year":"2014","unstructured":"Maki, T. et al. Phosphodiesterase III inhibitor promotes drainage of cerebrovascular \u03b2-amyloid. Ann. Clin. Transl Neurol. 1, 519\u2013533 (2014).","journal-title":"Ann. Clin. Transl Neurol."},{"key":"BFnrd2018109_CR303","doi-asserted-by":"crossref","first-page":"e89516","DOI":"10.1371\/journal.pone.0089516","volume":"9","author":"M Ihara","year":"2014","unstructured":"Ihara, M. et al. Cilostazol add-on therapy in patients with mild dementia receiving donepezil: a retrospective study. PLoS One 9, e89516 (2014).","journal-title":"PLoS One"},{"key":"BFnrd2018109_CR304","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1038\/s41598-018-20424-y","volume":"8","author":"I Lundgaard","year":"2018","unstructured":"Lundgaard, I. et al. Beneficial effects of low alcohol exposure, but adverse effects of high alcohol intake on glymphatic function. Sci. Rep. 8, 2246 (2018).","journal-title":"Sci. Rep."},{"key":"BFnrd2018109_CR305","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00401-017-1721-y","volume":"134","author":"WS Jin","year":"2017","unstructured":"Jin, W. S. et al. Peritoneal dialysis reduces amyloid-\u03b2 plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP\/PS1 mouse model. Acta Neuropathol. 134, 207\u2013220 (2017).","journal-title":"Acta Neuropathol."},{"key":"BFnrd2018109_CR306","first-page":"153","volume":"107","author":"M Domise","year":"2016","unstructured":"Domise, M. & Vingtdeux, V. AMPK in neurodegenerative diseases. EXS 107, 153\u2013177 (2016).","journal-title":"EXS"},{"key":"BFnrd2018109_CR307","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neuropharm.2012.11.015","volume":"68","author":"MJ Millan","year":"2013","unstructured":"Millan, M. J. An epigenetic framework for neurodevelopmental disorders: from pathogenesis to potential therapy. Neuropharmacology 68, 2\u201382 (2013).","journal-title":"Neuropharmacology"},{"key":"BFnrd2018109_CR308","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1096\/fj.201700999","volume":"32","author":"AJ Smith","year":"2017","unstructured":"Smith, A. J. & Verkman, A. S. The \u201cglymphatic\u201d mechanism for solute clearance in Alzheimer's disease: game changer or unproven speculation? FASEB J. 32, 543\u2013551 (2017).","journal-title":"FASEB J."},{"key":"BFnrd2018109_CR309","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fncel.2015.00017","volume":"9","author":"I Gonzalez-Marrero","year":"2015","unstructured":"Gonzalez-Marrero, I. et al. Choroid plexus dysfunction impairs \u03b2-amyloid clearance in a triple transgenic mouse model of Alzheimer's disease. Front. Cell Neurosci. 9, 17 (2015).","journal-title":"Front. Cell Neurosci."},{"key":"BFnrd2018109_CR310","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/1874609811003030219","volume":"3","author":"X Alvira-Botero","year":"2010","unstructured":"Alvira-Botero, X. & Carro, E. M. Clearance of amyloid-\u03b2 peptide across the choroid plexus in Alzheimer's disease. Curr. Aging Sci. 3, 219\u2013229 (2010).","journal-title":"Curr. Aging Sci."},{"key":"BFnrd2018109_CR311","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/978-3-319-57193-5_20","volume":"15","author":"A Jeromin","year":"2017","unstructured":"Jeromin, A. & Bowser, R. Biomarkers in neurodegenerative diseases. Adv. Neurobiol. 15, 491\u2013528 (2017).","journal-title":"Adv. Neurobiol."},{"key":"BFnrd2018109_CR312","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pharmthera.2017.02.009","volume":"175","author":"CTO Nguyen","year":"2017","unstructured":"Nguyen, C. T. O. et al. Retinal biomarkers provide \u201cinsight\u201d into cortical pharmacology and disease. Pharmacol. Ther. 175, 151\u2013177 (2017).","journal-title":"Pharmacol. Ther."},{"key":"BFnrd2018109_CR313","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1093\/brain\/awt144","volume":"136","author":"I Nascimento-Ferreira","year":"2013","unstructured":"Nascimento-Ferreira, I. et al. Beclin 1 mitigates motor and neuropathological deficits in genetic mouse models of Machado-Joseph disease. Brain 136, 2173\u20132188 (2013).","journal-title":"Brain"},{"key":"BFnrd2018109_CR314","doi-asserted-by":"crossref","first-page":"28220","DOI":"10.1038\/srep28220","volume":"6","author":"I Onofre","year":"2016","unstructured":"Onofre, I. et al. Fibroblasts of Machado Joseph Disease patients reveal autophagy impairment. Sci. Rep. 6, 28220 (2016).","journal-title":"Sci. Rep."},{"key":"BFnrd2018109_CR315","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s13238-015-0230-9","volume":"7","author":"P Song","year":"2016","unstructured":"Song, P. et al. Parkin promotes proteasomal degradation of p62: implication of selective vulnerability of neuronal cells in the pathogenesis of Parkinson's disease. Protein Cell 7, 114\u2013129 (2016).","journal-title":"Protein Cell"},{"key":"BFnrd2018109_CR316","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11910-015-0555-z","volume":"15","author":"R Martin-Jimenez","year":"2015","unstructured":"Martin-Jimenez, R., Campanella, M. & Russell, C. New zebrafish models of neurodegeneration. Curr. Neurol. Neurosci. Rep. 15, 33 (2015).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"BFnrd2018109_CR317","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.chembiol.2017.03.005","volume":"24","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Rescue of Pink1 deficiency by stress-dependent activation of autophagy. Cell Chem. Biol. 24, 471\u2013480 (2017).","journal-title":"Cell Chem. Biol."},{"key":"BFnrd2018109_CR318","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1083\/jcb.200904090","volume":"186","author":"T Wang","year":"2009","unstructured":"Wang, T., Lao, U. & Edgar, B. A. TOR-mediated autophagy regulates cell death in Drosophila neuro-degenerative disease. J. Cell Biol. 186, 703\u2013711 (2009).","journal-title":"J. Cell Biol."},{"key":"BFnrd2018109_CR319","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/bs.ctdb.2016.07.005","volume":"121","author":"VL Hewitt","year":"2017","unstructured":"Hewitt, V. L. & Whitworth, A. J. Mechanisms of Parkinson's disease: lessons from Drosophila. Curr. Top. Dev. Biol. 121, 173\u2013200 (2017).","journal-title":"Curr. Top. Dev. Biol."},{"key":"BFnrd2018109_CR320","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/02713683.2017.1370117","volume":"43","author":"S Miyake","year":"2017","unstructured":"Miyake, S., Takihara, Y., Yokota, S., Takamura, Y. & Inatani, M. Effect of microtubule disruption on dynamics of acidic organelles in the axons of primary cultured retinal ganglion cells. Curr. Eye Res. 43, 77\u201383 (2017).","journal-title":"Curr. Eye Res."},{"key":"BFnrd2018109_CR321","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4161\/auto.19716","volume":"8","author":"A Fouillet","year":"2012","unstructured":"Fouillet, A. et al. ER stress inhibits neuronal death by promoting autophagy. Autophagy 8, 915\u2013926 (2012).","journal-title":"Autophagy"},{"key":"BFnrd2018109_CR322","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pharmthera.2017.04.005","volume":"178","author":"K Palikaras","year":"2017","unstructured":"Palikaras, K., Daskalaki, I., Markaki, M. & Tavernarakis, N. Mitophagy and age-related pathologies: Development of new therapeutics by targeting mitochondrial turnover. Pharmacol. Ther. 178, 157\u2013174 (2017).","journal-title":"Pharmacol. Ther."},{"key":"BFnrd2018109_CR323","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fnmol.2017.00064","volume":"10","author":"M Martinez-Vicente","year":"2017","unstructured":"Martinez-Vicente, M. Neuronal mitophagy in neurodegenerative diseases. Front. Mol. Neurosci. 10, 64 (2017).","journal-title":"Front. Mol. Neurosci."},{"key":"BFnrd2018109_CR324","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1083\/jcb.201401070","volume":"206","author":"G Ashrafi","year":"2014","unstructured":"Ashrafi, G., Schlehe, J. S., LaVoie, M. J. & Schwarz, T. L. Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and Parkin. J. Cell Biol. 206, 655\u2013670 (2014).","journal-title":"J. Cell Biol."},{"key":"BFnrd2018109_CR325","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1093\/brain\/awx258","volume":"140","author":"F Du","year":"2017","unstructured":"Du, F. et al. PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer's disease. Brain 140, 3233\u20133251 (2017).","journal-title":"Brain"},{"key":"BFnrd2018109_CR326","doi-asserted-by":"crossref","first-page":"342ra78","DOI":"10.1126\/scitranslmed.aaf3634","volume":"8","author":"R Di Maio","year":"2016","unstructured":"Di Maio, R. et al. \u03b1-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease. Sci. Transl Med. 8, 342ra78 (2016).","journal-title":"Sci. Transl Med."},{"key":"BFnrd2018109_CR327","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nchembio.2287","volume":"13","author":"ND Georgakopoulos","year":"2017","unstructured":"Georgakopoulos, N. D., Wells, G. & Campanella, M. The pharmacological regulation of cellular mitophagy. Nat. Chem. Biol. 13, 136\u2013146 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"BFnrd2018109_CR328","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.cell.2013.07.030","volume":"154","author":"NT Hertz","year":"2013","unstructured":"Hertz, N. T. et al. A neo-substrate that amplifies catalytic activity of parkinson's-disease-related kinase PINK1. Cell 154, 737\u2013747 (2013).","journal-title":"Cell"},{"key":"BFnrd2018109_CR329","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1021\/cb5010417","volume":"10","author":"SA Hasson","year":"2015","unstructured":"Hasson, S. A. et al. Chemogenomic profiling of endogenous PARK2 expression using a genome-edited coincidence reporter. ACS Chem. Biol. 10, 1188\u20131197 (2015).","journal-title":"ACS Chem. Biol."},{"key":"BFnrd2018109_CR330","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/nsmb.3475","volume":"24","author":"M Gersch","year":"2017","unstructured":"Gersch, M. et al. Mechanism and regulation of the Lys6-selective deubiquitinase USP30. Nat. Struct. Mol. Biol. 24, 920\u2013930 (2017).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"BFnrd2018109_CR331","doi-asserted-by":"crossref","first-page":"e1003510","DOI":"10.1371\/journal.ppat.1003510","volume":"9","author":"D Dutta","year":"2013","unstructured":"Dutta, D. et al. EphrinA2 regulates clathrin mediated KSHV endocytosis in fibroblast cells by coordinating integrin-associated signaling and c-Cbl directed polyubiquitination. PLoS Pathog. 9, e1003510 (2013).","journal-title":"PLoS Pathog."},{"key":"BFnrd2018109_CR332","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.chembiol.2014.09.019","volume":"21","author":"DA East","year":"2014","unstructured":"East, D. A. et al. PMI: a DeltaPsim independent pharmacological regulator of mitophagy. Chem. Biol. 21, 1585\u20131596 (2014).","journal-title":"Chem. Biol."},{"key":"BFnrd2018109_CR333","doi-asserted-by":"crossref","first-page":"19304","DOI":"10.1074\/jbc.M112.363747","volume":"287","author":"SY Jang","year":"2012","unstructured":"Jang, S. Y., Kang, H. T. & Hwang, E. S. Nicotinamide-induced mitophagy: event mediated by high NAD+\/NADH ratio and SIRT1 protein activation. J. Biol. Chem. 287, 19304\u201319314 (2012).","journal-title":"J. Biol. Chem."},{"key":"BFnrd2018109_CR334","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.bbadis.2017.06.011","volume":"1863","author":"B Wu","year":"2017","unstructured":"Wu, B. et al. Succinate-induced neuronal mitochondrial fission and hexokinase II malfunction in ischemic stroke: therapeutical effects of kaempferol. Biochim. Biophys. Acta 1863, 2307\u20132318 (2017).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrd2018109_CR335","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nm.4132","volume":"22","author":"D Ryu","year":"2016","unstructured":"Ryu, D. et al. Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nat. Med. 22, 879\u2013888 (2016).","journal-title":"Nat. Med."},{"key":"BFnrd2018109_CR336","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/jnr.24121","volume":"96","author":"MJ Hylin","year":"2018","unstructured":"Hylin, M. J. et al. A role for autophagy in long-term spatial memory formation in male rodents. J. Neurosci. Res. 96, 416\u2013426 (2018).","journal-title":"J. Neurosci. Res."},{"key":"BFnrd2018109_CR337","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/cbic.201600515","volume":"18","author":"JH Lee","year":"2017","unstructured":"Lee, J. H. & Lee, M. J. Isolation and characterization of RNA aptamers against a proteasome-associated deubiquitylating enzyme UCH37. Chembiochem. 18, 171\u2013175 (2017).","journal-title":"Chembiochem."},{"key":"BFnrd2018109_CR338","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1021\/acs.molpharmaceut.6b00165","volume":"13","author":"JH Kim","year":"2016","unstructured":"Kim, J. H. et al. Inhibitory RNA aptamers of Tau oligomerization and their neuroprotective roles against proteotoxic stress. Mol. Pharmaceut. 13, 2039\u20132048 (2016).","journal-title":"Mol. Pharmaceut."},{"key":"BFnrd2018109_CR339","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1021\/ac300330g","volume":"84","author":"K Tsukakoshi","year":"2012","unstructured":"Tsukakoshi, K., Abe, K., Sode, K. & Ikebukuro, K. Selection of DNA aptamers that recognize \u03b1-synuclein oligomers using a competitive screening method. Anal. Chem. 84, 5542\u20135547 (2012).","journal-title":"Anal. Chem."},{"key":"BFnrd2018109_CR340","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/bpa.12267","volume":"26","author":"H Wang","year":"2016","unstructured":"Wang, H. et al. MiR-124 regulates apoptosis and autophagy process in MPTP model of Parkinson's disease by targeting to Bim. Brain Pathol. 26, 167\u2013176 (2016).","journal-title":"Brain Pathol."},{"key":"BFnrd2018109_CR341","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.neuron.2017.04.010","volume":"94","author":"KM Schoch","year":"2017","unstructured":"Schoch, K. M. & Miller, T. M. Antisense oligonucleotides: translation from mouse models to human neurodegenerative diseases. Neuron 94, 1056\u20131070 (2017).","journal-title":"Neuron"},{"key":"BFnrd2018109_CR342","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrd.2016.211","volume":"16","author":"CC Lai","year":"2017","unstructured":"Lai, C. C. & Crews, C. M. Induced protein degradation: an emerging drug paradigm. Nat. Rev. Drug Discov. 16, 101\u2013114 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnrd2018109_CR343","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1021\/acs.jmedchem.6b01781","volume":"61","author":"RP Wurz","year":"2017","unstructured":"Wurz, R. P. et al. A \u201cclick chemistry platform\u201d for the rapid synthesis of bispecific molecules for inducing protein degradation. J. Med. Chem. 61, 453\u2013461 (2017).","journal-title":"J. Med. Chem."},{"key":"BFnrd2018109_CR344","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/15548627.2015.1136769","volume":"12","author":"M Bourdenx","year":"2016","unstructured":"Bourdenx, M. et al. Nanoparticles restore lysosomal acidification defects: implications for Parkinson and other lysosomal-related diseases. Autophagy 12, 472\u2013483 (2016).","journal-title":"Autophagy"},{"key":"BFnrd2018109_CR345","doi-asserted-by":"crossref","first-page":"246","DOI":"10.5607\/en.2014.23.3.246","volume":"23","author":"PY Gambaryan","year":"2014","unstructured":"Gambaryan, P. Y., Kondrasheva, I. G., Severin, E. S., Guseva, A. A. & Kamensky, A. A. Increasing the efficiency of Parkinson's disease treatment using a poly(lactic-co-glycolic acid) (PLGA) based L-DOPA delivery system. Exp. Neurobiol. 23, 246\u2013252 (2014).","journal-title":"Exp. Neurobiol."},{"key":"BFnrd2018109_CR346","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.copbio.2015.08.016","volume":"36","author":"L Popp","year":"2015","unstructured":"Popp, L. & Segatori, L. Differential autophagic responses to nano-sized materials. Curr. Opin. Biotechnol. 36, 129\u2013136 (2015).","journal-title":"Curr. Opin. Biotechnol."},{"key":"BFnrd2018109_CR347","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.neuron.2012.02.020","volume":"74","author":"D Hernandez","year":"2012","unstructured":"Hernandez, D. et al. Regulation of presynaptic neurotransmission by macroautophagy. Neuron 74, 277\u2013284 (2012).","journal-title":"Neuron"},{"key":"BFnrd2018109_CR348","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.brainres.2011.02.041","volume":"1386","author":"Y Han","year":"2011","unstructured":"Han, Y., Khodr, C. E., Sapru, M. K., Pedapati, J. & Bohn, M. C. A. microRNA embedded AAV \u03b1-synuclein gene silencing vector for dopaminergic neurons. Brain Res. 1386, 15\u201324 (2011).","journal-title":"Brain Res."},{"key":"BFnrd2018109_CR349","doi-asserted-by":"crossref","first-page":"343re2","DOI":"10.1126\/scitranslmed.aaf6086","volume":"8","author":"A Carpentier","year":"2016","unstructured":"Carpentier, A. et al. Clinical trial of blood-brain barrier disruption by pulsed ultrasound. Sci. Transl Med. 8, 343re2 (2016).","journal-title":"Sci. Transl Med."},{"key":"BFnrd2018109_CR350","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neuroscience.2016.02.054","volume":"324","author":"J Jeon","year":"2016","unstructured":"Jeon, J., Kim, W., Jang, J., Isacson, O. & Seo, H. Gene therapy by proteasome activator, PA28\u03b3, improves motor coordination and proteasome function in Huntington's disease YAC128 mice. Neuroscience 324, 20\u201328 (2016).","journal-title":"Neuroscience"},{"key":"BFnrd2018109_CR351","doi-asserted-by":"crossref","first-page":"E1817","DOI":"10.1073\/pnas.1305623110","volume":"110","author":"M Decressac","year":"2013","unstructured":"Decressac, M. et al. TFEB-mediated autophagy rescues midbrain dopamine neurons from \u03b1-synuclein toxicity. Proc. Natl Acad. Sci. USA 110, E1817\u20131826 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd2018109_CR352","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature20587","volume":"540","author":"HF Iaccarino","year":"2016","unstructured":"Iaccarino, H. F. et al. Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature 540, 230\u2013235 (2016).","journal-title":"Nature"}],"container-title":["Nature Reviews Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrd.2018.109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrd.2018.109","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nrd.2018.109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nrd.2018.109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:40:07Z","timestamp":1684453207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrd.2018.109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,17]]},"references-count":352,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["BFnrd2018109"],"URL":"https:\/\/doi.org\/10.1038\/nrd.2018.109","relation":{},"ISSN":["1474-1776","1474-1784"],"issn-type":[{"value":"1474-1776","type":"print"},{"value":"1474-1784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,17]]},"assertion":[{"value":"17 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.J.M. is a full-time employee of Servier Pharmaceuticals and has no other competing interests to declare. E.B. has an equity stake in Motac Holding Ltd. and receives consultancy payments from Motac Neuroscience Ltd. D.C.R. is a consultant for E3Bio and has consulted for GlaxoSmithKline, AbbVie and AstraZeneca. He has received grant support from AbbVie and AstraZeneca. B.L. is a scientific founder of Casma Therapeutics. A.H. is a full-time employee of Neuro-Sys and has no other competing interests to declare. C.L. is a full-time employee of Servier Pharmaceuticals and has no other competing interests to declare. M.S. is a consultant for Servier Pharmaceuticals and President of Spedding Research Solutions SAS, a company performing research on potential therapies for amyotrophic lateral sclerosis. The author others declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}